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Stroke is the third cause of death behind diseases of the heart and cancer 
worldwide. There are about 1.5 million people suffer from stroke in China each year 
and cause one million death in China. Stroke causes long-lasting disability and even 
death to patients. Although many formulas of traditional Chinese medicine were used 
to treat stroke patients for a long time, evidence on the effectiveness of these formulas 
is lacking. A compound formula, post-stroke rehabilitation formula (PSR), was used 
in this study. It contains seven herbs namely Radix Angelicae Sinensis, Radix 
Glycyrrhizae, Radix Salviae Miltorrhizae, Cassia Obtusifolia Linne, Astragali Radix, 
Paeoniae Veitchii Radix and Rhizoma Chuanxiong. These herbs were chosen because 
of their well-known anti-oxidative and anti-inflammatory activities and it has been 
reported that free-radicals-mediated damages always impose damage in stroke. 
The in vitro oxygen and glucose deprivation (OGD) experiment demonstrated 
that PSR at concentration of 125 ^ig/ml or above could significantly reduce the death 
of neuroblastoma cells which are commonly used to refer the cells of central nervous 
system. Also, higher cell viability was observed with shorter OGD incubation. PSR 
could reduce neuronal cell death in a dose-dependent and time-dependent manner. 
Middle cerebral artery occlusion (MCAo) was employed as an in vivo model to 
evaluate the effectiveness of PSR in treating stroke. Among different endovascular 
xviii 
techniques for MCAo, the suture occlusion technique is the most commonly used 
method. It gives reproducible MCA territory infarctions and allows reperfusion by 
retracting the suture. In this model, all animals underwent focal ischemia for 2 hours, 
followed by 24 hours reperfusion. PSR was orally administered to the rats at first and 
second hour after onset of reperfusion. The brain infarction volume was significantly 
reduced when the rats were treated with ten times of human equivalent dose (HED) of 
PSR. Besides, ten times of HED of PSR could significantly enhance the superoxide 
dismutase (SOD) activity. Apart from the PSR, a compound, Salvianolic acid B (SAB) 
from Radix Salviae Miltorrhizae was also tested. A significant reduction in brain 
infarction was observed when the rats were treated by 40 mg/kg of SAB. Shuttle box 
escape experiment was carried out as behavioral test to evaluate the effects of PSR on 
post-stroke rehabilitation. The escape performance in an active avoidance test of the 
ischemic PSR-treated group and ischemic SAB-treated group was significantly 
improved when compared with the ischemic saline-treated group. 
In conclusion, both PSR and SAB could protect the brain from 
ischemia-reperfusion damage in in vivo study. Also, the results from behavioral test 


















灌胃給予P S R�而十倍人體等效劑量的P S R能夠有效地減少大白鼠的腦部阻 




作爲行爲實驗去測試P S R及丹蔘®酸B對中風後康復的影響。結果顯示藥物組 
在第八天的實驗中的表現明顯地比控制組優勝。 
總括而言，在動物模型實驗的結果中顯示出P SR及丹蔘酣酸B能有效地減 
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Chapter 1 Introduction 
Chapter 1 
Introduction 
1.1 General introduction to cerebral stroke 
According to World Health Organization, the definition of stroke is "rapidly 
developing clinical signs of focal or global disturbance of cerebral function, with 
symptoms lasting 24 hours or longer or leading to death, with no apparent cause 
except of vascular origin" (Aho et al.，1980). Cerebral stroke is a process of the death 
of brain cells due to an insufficient blood supply. It can be caused by the blockage of 
blood flow to the brain, either transiently or permanently. In the ischemic core, the 
energy demand cannot be met and the anoxic depolarization develops within minutes. 
Since the ion homeostasis is lost and the failure of cellular energy, the brain cells are 
killed by proteolysis and lipolysis rapidly (Ferrer and Planas, 2003). The area 
surrounding the infarct core is called penumbra, and damage within this area is milder 
than that in infarct core. Blood flow within penumbra is constrained, such reduction 
causes arrest of the physiological function, however, not causing cellular necrosis 
(Weinstein et al., 2004). The penumbra will change into infarction with time because 
of some excitotoxic mechanism. Since brain is damaged, patient will suffer from 
severe disability or even death (Rodriguez-Gonzalez et a l , 2007). 
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1.2 Different types of cerebral stroke 
There are two types of cerebral stroke, hemorrhagic stroke and ischemic stroke. 
Hemorrhagic stroke is due to the ruptures of cerebral blood vessel. This will lead to 
intracerebral hemorrhage which is about bleeding into brain tissue (Collins, 2007). 
Ischemic stroke is caused by the occlusion of an intracranial artery. When the cerebral 
vessel and those vessels that transport blood to the brain are blocked by blood clot, the 
nutrients and the oxygen supplied to the brain are reduced. If the brain tissue under 
hypoxia and hypoglycemia conditions for a period of several hours or days, an infarct, 
a lesion defined as an area of coagulation necrosis of ischemic origin, will be 
produced (Garcia et al.，1993;Garcia et al.，1996). There are two kinds of ischemic 
stroke, which are embolic stroke and thrombotic stroke. Embolic stroke is caused by 
the blockage of the cerebral blood vessel by solid emboli. When the emboli formed 
and detached from the large artery, it will travel along the blood stream and lodge in 
smaller artery that lead to the brain or in the brain (Chung et al., 2007). Finally, the 
brain will suffer from ischemia. Thrombotic stroke, the most common type of stroke, 
is caused by atherosclerosis in the cerebral blood vessels and occlusion was the result 
(Conway, 2003). 
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1.3 Statistics 
Cerebral stroke is a major cause of death and long-term disability (Hankey et al.， 
2002). According to the report of World Health Organization (WHO), cerebral stroke 
contribute 10% of the total causes of death in 2002. About 15-million people suffer 
from stroke each year, one third of them are died and the other 5 millions are suffered 
from permanent disabilities. About one-sixth of people will suffer at least one stroke 
throughout their lives (Seshadri and Wolf, 2007). In America, one person die from 
stroke every three minutes. Besides, stroke is the major cause of disability in United 
Kingdom. In China, there are about 1.5 to 2-million people suffering from new stroke 
each year (Liu et al., 2007b). The fatality rate after first cerebral stroke are about 7% 
within 7 days; 14% within 30 days; 27% within 1st year and 53% for 5 years (Petty et 
al., 1998). About 65% of the hospitalized stroke survivors show initial motor deficits. 
However, less than 15% of the patients with paralysis show complete motor recovery 
(Hendricks et al., 2002). Since about 5-million stroke patients with permanent 
disabilities, it causes a heavy burden on family and community. Stroke burden costs 
globally about 38 millions per day in 1990, and it will rise to around 61 millions per 
day in 2020. Around fifty-one billion US dollars are spent on acute care and long-term 
consequences of stroke every year in America. Understanding cerebral stroke and 
searching for alternative methods for treatment can help reducing the load from stroke 
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and improving patient's "quality of life of the patients". 
1.4 Symptoms of cerebral stroke 
Cerebral stroke is a medical emergency, stroke symptoms usually develop rapidly. 
The common signs of cerebral stroke including facial paresis, arm drift, and abnormal 
speech (Goldstein and Simel, 2005). Besides, cerebral stroke could cause hemiparesis, 
paralysis of the tongue, diplopia, and dizziness. Sometimes, the patients show 
quadriparesis which means the sensory function of both four limbs are lost (Burger et 
al., 2005). Actually, the symptoms developed depend on which territory in the brain is 
affected. 
For the anterior cerebral artery (ACA) infarcts, the most common clinical feature 
of ACA infarcts is motor weakness which almost appears in all patients. The paresis 
usually involves the lower limb. Facial weakness can be observed after deep infarcts 
(Caplan et al., 1990). Also, if the lesion extended into deep structure, complete 
hemiparesis would be resulted. For the language disorder, both mutism and aphasia 
would be occurred when left lesion is present. 
For the anterior choroidal artery (AChA) infarcts, this kind of stroke is rare. 
Again, a serious motor weakness of face and limbs are presented (Decroix et al., 
1986). Besides, visual neglect, motor impersistence and eye and head deviation could 
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be observed if the patient suffers from large infarcts (Helgason et al., 1986). 
For the middle cerebral artery (MCA) infarcts, this infarct makes up 34.5% of all 
ischemic cerebral strokes. MCA infarcts cause massive hemiplegia. Global aphasia 
and visuospatial impairment would be the result of left and right side lesion 
respectively (Hallevy et al., 2002). Besides, the occurrence of edema will lead to 
unconsciousness. 
For the posterior cerebral artery (PCA) infarcts, visual symptoms, including 
visual lost and unable to distinguish different colors, are usually shown in the patients. 
Sometimes, memory and learning disturbance can be found in the patients who are 
suffered from PCA infarct (Brandt et al., 2000). 
For the medullary infarcts, this kind of infarction is associated with contralateral 
hemiparesis and ipsilateral facial sensory loss. However, facial pain is commonly 
found within the patients. Besides, dizziness is one of the symptoms of medullary 
infarct (Kim et al., 1995). 
1.5 Complications of cerebral stroke 
One of the most frequent complications of cerebral stroke is progressive 
neurological deficit. Typically, such neurological deterioration will be terminated 
within the first two days after onset of stroke. The neurological deficit is due to edema 
5 
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formation and extension of the infarct (Davalos et al., 1990). Moreover, stroke 
recurrence increases the death rate but the rate of stroke recurrence can be reduced by 
daily intake of aspirin (PAG Sandercock, 1997). Edema formation usually occur 
between 2"'' to day after onset of stroke, and causing drowsiness and hemiparesis 
(Frank, 1995). Osmotic agent and hyperventilation are employed to reduce the 
pressure in the brain. Besides, cardiac complications could be found in the stroke 
survivor, coronary artery disease and rhythmic disorder are the complication of 
ischemic stroke. It was reported that those cardiac complications are commonly 
occurring in the patient with right hemisphere infarction. Other complications, 
including infections (e.g. pneumonia and urinary tract infections), fever, urinary and 
fecal incontinence, dysphagia and malnutrition could also be found in the stroke 
patients. Besides the physical and systemic complications, psychiatric complications 
is a vital problem that affecting the patients. Confusion and mood disorders can be 
observed at the first two weeks after onset of stroke (Fassbender et al., 1994). 
1.6 Risks and preventions of cerebral stroke 
Understanding the risks of stroke and the ways of prevention is an effective way 
to reduce its societal burden. About 70% of the total case of cerebral stroke is 
ischemic stroke. As atherosclerosis of the heart and brain vessel play the dominant 
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pathological role of ischemic stroke, most of the risk factors of cerebral stroke are 
associated with atherosclerosis (Gorelick et al., 1999; Straus et al., 2002). 
Hypertension is one of the most common risk factors of stroke. It has been reported 
that 5 to 6 mmHg reduction in systolic pressure and 2 to 3 mmHg reduction in 
diastolic blood pressures would result in 40% fewer strokes (Collins et al., 1990). 
Lowering the blood pressure helps preventing both ischemic and hemorrhagic strokes. 
Besides, cholesterol level is associated with stroke. The risk of suffering from 
ischemic stroke is higher if the level of total and low-density lipoprotein (LDL) 
cholesterol are higher (Psaty et al., 2003). Also, statins could reduce the risk of 
suffering stroke by 15% (O丨Regan et al., 2008). People with diabetes mellitus have 
higher risk in developing stroke (about 2 to 3 times higher). This may due to the fact 
that hypertension and hyperlipidemia are commonly found in those people with 
diabetes mellitus (Dormandy et al., 2005). Moreover, atrial fibrillation has been linked 
with increased stroke incidence. 5% of those patients with atrial fibrillation suffer 
from stroke each year (Wolf et al., 1987). As inflammation and infections are the 
important risk factors of atherosclerosis, it has been demonstrated the linkage between 
infections and stroke (Libby et al., 2002;Ross, 1999). Besides, about 8% of children 
with sickle cell disease suffer from stroke; though, stroke is not common among youth. 
Apart from the previous risk factors, both smoking, alcohol abuse, lack of exercise, 
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unhealthy diet and obesity could increase the risk of suffering stroke (Reynolds et al., 
2003). 
There are several ways to prevent suffering from stroke, for example, 
antihypertensive drug can be used when the blood pressure is increased. Statin can 
help lowering the elevated cholesterol level. Besides, warfarin can be employed to 
treat nonrheumatic atrial fibrillation. Actually, optimization of lifestyle is one of the 
most effective ways to reduce stroke incidence. Alcohol restriction, regular exercise 
and smoking cessation are benefit to reduce the risk (Ezekowitz et al., 2003). 
1.7 Cerebral stroke treatment 
Before starting treatment, diagnosis is carried out to evaluate the status of the 
stroke patients. Understanding the type and extent of stroke is one of the most 
important criteria for providing proper medication to the patients. Neurological 
examinations are usually performed in order to confirm the suspicion of stroke and 
provide the idea about the territory of stroke (Ustrell-Roig and Serena-Leal, 2007). 
Cardiac examination is one of the essential parts of the diagnosis because both 
ischemic and hemorrhagic stroke could disturb the normal cardiac function 
(Khechinashvili and Asplund, 2002). Electrocardiogram (ECG) and transthoracic 
echocardiogram (TTE) are usually employed for the cardiac assessment. Besides, 
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magnetic resonance imaging (MRI) and computed tomography (CT) scan are 
commonly used for further assessment. Such imaging techniques can provide a lot of 
information including whether the patient from hemorrhagic or ischemic stroke, the 
location of the lesions and the size of the lesions (Sanelli et al., 2002). Moreover, 
these techniques can also give the cerebrovascular images and hence provide the 
information about the occluded vessels involved in ischemic stroke (Gallego and 
Martinez-Vila, 2005). MRI and CT scan can also be applied on evaluating severity of 
hemorrhagic stroke. Important information, such as infarction size, drainage patterns, 
amount of edema and lesion territory can be read from this machine. In addition, 
blood test plays an important role in understanding the pathogenesis of both kinds of 
cerebral stroke. American Heart Association (AHA) suggests that complete blood 
count, platelet count, prothrombin time, partial thromboplastin time, serum 
electrolytes, blood glucose, arterial blood gas levels (if hypoxia is suspected), and 
renal and hepatic chemical analyses should be performed in the patients with acute 
ischemic stroke (Adams, Jr. et al., 1994). The goals of different diagnosis are to 
identify the region of lesions and the occluded blood vessel, to recognize the risk for 
further stroke and complications, and giving the most suitable treatment to the 
patients. 
For the treatment of ischemic cerebral stroke, clot-busters, for example tissue 
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plasminogen activator (t-PA), provide the most promising treatment. However, t-PA 
should be administered within three hours from the onset of symptoms in order to 
prevent cerebral hemorrhage. Since the therapeutic window is quite short, only 3 to 
5% fulfill the criteria and receive such treatment (Bright and Mochly-Rosen, 2005). It 
was reported that patients treated with t-PA were about 30% more likely to have 
minimal or no disability than that of patients treated with placebo. However, increased 
intracranial hemorrhages is the drawback of using t-PA. Such problem can be 
minimized by using lower dose of t-PA in earlier treatment (John R.Marler, 1995). 
In addition, mechanical thrombectomy can also be used to remove the blood 
clots. In this method, a catheter will first be inserted into the femoral artery and 
leading it into the cerebral circulation. The microcatheter is then placed through the 
occlusion and the retriever, a corkscrew-like device, is advanced distal to the clot and 
deployed. Finally the clot is ensnared and both microcatheter and retriever are 
retracted together with the blood clot. Combining t-PA treatment with mechanical 
thrombectomy can improve the rate of recanalization. Nevertheless, mechanical 
thrombectomy should be performed within eight hours after the symptom onset 
(Smith, 2006). 
For the hemorrhagic stroke, the treatments are aim at stopping bleeding, reducing 
cerebral pressure and stabilizing vital signs. Unlike ischemic stroke, anticoagulants 
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and thrombolytic drugs are not given to the patient as those drugs will make bleeding 
worse. The patient should receive haemostatic therapy in order to help blood clotting. 
For instance, intravenous administration of vitamin K and transfusions of platelets are 
commonly used in stopping cerebral bleeding. If large amount of bleeding has 
occurred, surgery should be done to remove the accumulated blood and relieve 
pressure. Most neurosurgeons believe cerebral hemorrhages with larger than three 
centimeters could be benefit from early surgical intervention. Actually, surgery is not 
recommended as operation itself can damage the brain. Additionally, removing the 
accumulated blood will promote extra bleeding and finally causing further brain 
damage and leading to severe disability (Sahni and Weinberger, 2007). 
1.8 Post stroke rehabilitation 
Stroke rehabilitation is the process that helping disabled stroke patient returns to 
normal life by releaming the skills of daily life. The goals of rehabilitation are let the 
patients recognize and get used to their impediments. Also, understanding the risk of 
recurrence of stroke, preventing secondary complications, minimizing the pain and 
distress experienced of the patient and educating the family members are the major 
objectives of rehabilitation. A complete rehabilitation program should not only 
concern about the physiological problems but also psychological and social problems, 
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Before starting the rehabilitation program, assessment should be carried out to 
identify the nature and extent of the patients' problem. The aim of assessment is 
collecting and interpreting the information of the patients in order to understand the 
difficulties of the patient and then setting the target of the rehabilitation program. 
There are several tests to assess the degree of disability of the patient, for instance, 
Barthel Activities of Daily Living (ADL) (Laake et al., 1995) and Functional 
Independence Measure (FIM) (Sangha et al., 2005). Continuous monitoring the 
patients' performance can help evaluating the efficiency of the rehabilitation program 
and taking reaction immediately. 
A group of professionals should work together as a team during rehabilitation. 
Such rehabilitation team usually consists of physical, occupational, speech and 
language therapists, clinical neurophysiologists, doctors, nurses and social workers. 
Different professionals could help patients to recover in different aspects. All the team 
members share the common goal during rehabilitation program. Therefore, goal 
planning and setting is vital to the success of rehabilitation. It was reported that the 
patient shows more behavioral change when there is goal planning and goal setting. 
Also, patient participation is vital in setting an optimal goal. Setting both short term 
and long term goal is more effective than only setting the long term goal (Wade, 
1998). 
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As mentioned before, there are three different aspects in post-stroke 
rehabilitation, including physiological, psychological and social problems. For the 
physiological problem, it mainly concern about the motor deficits and the pain 
suffered by the patient. One of the most common motor deficits is spastic hemiparesis, 
muscle weakness, fatigue, spasticity and reduced coordinating ability affect the 
normal daily life of the patient. Physiotherapy will be given to the patient in order to 
improve their limb function and reduce spasticity. Both active training of movement 
and passive therapies will be given to the patient. The aims of both treatments are to 
strengthen the muscle，improving mobility recovery and reducing spasticity (Ivey et 
al., 2006). For the pain management, hemiplegic shoulder pain (HSP) is very common 
after stroke. It negatively affects the recovery of arm functions and independence of 
daily living. HSP may develop after two weeks or several months after stroke. 
Patients with HSP sense sharp pain when their arm moved to the end range of 
movement at shoulder. External support and range-of-motion exercise can help 
reducing pain and enhancing the range of shoulder movement (Gilmore et al., 2004). 
About 35% of stroke patient with post stroke depression (PSD), therefore 
psychologist should be a member of the rehabilitation team. PSD can significantly 
affect the functional recovery of the patient. There are several drugs available for 
treating PSD, for example, tricyclic antidepressants and selective serotonin reuptake 
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inhibitors. The depressed patient treated with anti-depressants has better functional 
improvement than those in the untreated group (van de Weg et al.，1999). 
Cognitive impairment is another frequent complication in stroke patients and 
leads to dementia. About 70% of stroke survivors have cognitive impairment (Kase et 
al., 1998). Actually, cognitive impairment is a general term of several mental deficits, 
for instance, attention, visual perception, language and communication, memory, and 
executive functioning deficits. Cognitive rehabilitation is a "systematic, functionally 
oriented service of therapeutic activities that is based on assessment and 
understanding of the patient's brain-behavioral deficits" (Cicerone et al., 2005). 
Memory deficit is one of the most common cognitive impairments, and such deficit 
affects both retrospective memory and prospective memory of the patient. Moreover, 
this cognitive impairment affects patient's independence. The focuses of memory 
rehabilitation are helping the patients remember and recall information. Learning how 
to use the internal and external memory aids is one of the aims during rehabilitation 
program. The example of internal memory aids including mnemonics and rehearsal 
while external memory aids are the use of diaries and notice boards. Learning new 
techniques can reduce patients' memory and planning problems (Nair and Lincoln, 
2007). 
Occupational therapy helps the patient releam daily activities, such as eating, 
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dressing, bathing, and toileting. Besides, speech and language therapy let the patient 
releams how to use language or develops alternative means of communication. Also, 
speech and language therapy teaches the patient how to deal with the problem of 
eating. Furthermore, social worker can help the patients re-enter the society. All the 
parties of the rehabilitation team should put their effort on increasing the quality of 
life of the patient. 
1.9 Mechanisms of stroke 
1.9.1 Energy production failure and loss of ionic homeostasis 
There are several specific features of brain, such as high metabolic rate and 
depending on aerobic metabolism of glucose. Also the energy storage in brain is 
limited. Thus, continuous blood supply is vital to brain. When the brain under 
ischemic condition (shortage of blood supply), both hypoxia and hypoglycemia will 
be the result. When the cerebral vessel is blocked, blood supply to brain become 
failure, normal brain glucose level cannot be met and hence, the ATP level fall. Loss 
of normal ATP level affects the normal function of several ion pumps. Disruption of 
the normal function of sodium-potassium pump will fail in maintaining the 
transmembrane ion gradients. In normal condition, this transporter keeps the high 
intracellular concentrations of potassium and low intracellular concentrations of 
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sodium in order to maintain the cell potential. Since the sodium-potassium pump 
pumps sodium out and potassium in through active transport and ATP consumption. 
ATP production failure affects the normal function of transporter and result in 
membrane depolarization and eventually cell death. Besides, under hypoxia condition, 
brain cells undergo glycolysis rather than aerobic metabolism and lactic acidosis will 
be the result. The pH value in the ischemic tissues usually drops from 7.3 (normal pH 
value) to about 6.5. The acute change of ATP, H+, and calcium ions causes the opening 
of potassium channels and subsequently neuronal hyperpolarization. As 
hyperpolarization occurred, the normal brain functions are stopped. Afterward, 
depolarization increases the extracellular potassium concentration, and the 
intracellular calcium and sodium concentration continuously. Influx of calcium ions 
triggers the release of neurotransmitter, such as, glutamate. At the same time, the 
disrupted sodium ions gradient leads to impairment in re-uptake of neurotransmitter. 
As the release of glutamate is enhanced and the re-uptake of glutamate is blocked, the 
extracellular glutamate increased (Henry et al., 1998). 
1.9.2 Excitotoxicity 
Excitotoxicity is a pathological process which about the neuronal cells are 
injured or killed by glutamate. Such damaging process occurs when the glutamate 
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receptors, such as N-methyl-D-aspartate (NMDA) receptor and 
a-amino-3-hydroxy-5-methyI-4-isoxazole propionic acid (AMPA) receptors/kainate 
(KA) receptors, are over-activated. In fact, if the NMDA receptor has been activated 
by three minutes, it is enough to start the neuronal death. As mentioned before, the 
extracellular glutamate level increased during ischemia and thus, the glutamate 
receptors are over-stimulated and eventually leading to neuronal cell death. Activation 
of NMDA receptors has been proposed as a primary cause of neuronal death during 
cerebral stroke. When glutamate binds to NMDA receptor (NMDA-R) and AMPA/KA 
type of glutamate receptor, it will trigger the influx of calcium and sodium ions. 
Hence, drastic exposure of glutamate to the glutamate receptor leads to intracellular 
sodium and calcium ions overload and causing neuronal cell death (Henry et al., 
1998). 
1.9.3 Calcium ions mediated toxicity 
Since the active calcium pumps do not function normally as the energy 
production failure, elevated intracellular calcium ions concentration cannot be 
reduced. Prolonged elevation of cytosolic calcium ions concentration initiates the 
catabolic reactions of vital molecules and causes neuronal cells death. These catabolic 
reactions involve several enzymes, for instance calpains，endonucleases, protein 
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kinases and cytosolic phospholipase A2 (cPLA2). Activated calpains, a 
Ca^^-dependent cysteine proteases, cleaves several vital proteins, such as Ca^ "^ -
ATPase and protein kinase C. Cleavage of such vital protein leads to neuronal 
degeneration (Carafoli and Molinari, 1998). 
Drastic influx of calcium ions activates Ca^^-dependent endonucleases. Also the 
decrease in pH value activates DNase. Activation of endonucleases leads to DNA 
breakdown. For the Ca^^-dependent protein kinases, it was reported that 
Ca2+-dependent protein kinases inhibitor could reduce the neuronal cell death. cPLA2 
translocates into plasma membrane when the cytosolic calcium ions elevated. The 
activated cPLA2 catalyzes the cleavage of free fatty acid from glycerophospholipids 
and liberate arachidonic acid and lysophospholipids. Further metabolism of 
arachidonic acid will produce superoxide together with prostaglandins and 
leukotrienes (Won et al., 2002). 
1.9.4 Passive neuronal cell death 
Neuronal cell death in the infarct core is mainly due to necrosis which is 
characterized by the rapid energy and metabolic failure, membrane disruption and 
rupture of the organelles. Besides, low ATP level within the infarct core encourage 
necrosis since ATP is required for initiating apoptosis. ATP is essential for forming 
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apoptosome and hence, activating the caspase cascade. Thus, depletion of ATP favors 
necrosis rather than apoptosis. Also, as the damage within the infarct core is rapid, 
there is only little therapeutic expectation for this area (Ferrer, 2006). 
1.9.5 Oxidative stress 
Oxidative stress is one of the major causes of brain damage during cerebral 
stroke. Free radical generation during ischemia and reperfusion damages the neuronal 
cells, causes brain edema and breakdown of blood brain barrier. Free radicals are the 
atom or molecule with unpaired electrons on their outer electron orbital. Those 
unpaired electrons are usually highly reactive, thus free radicals involve in many 
chemical and biological reactions. There are several free radicals are commonly found, 
such as superoxide (O2.-)，hydroxyl radical (. OH) and nitric oxide (NO.). Exposure to 
these free radicals cause several adverse effects, including damaging the lipids, 
protein and nucleic acids. Free radicals damage the unsaturated fatty acid by lipid 
peroxidation. The free radicals react with the unsaturated bond of the side chains of 
the polyunsaturated fatty acid. Since reaction with free radicals will generate other 
free radicals, lipid peroxidation is a kind of chain reaction mechanism. Such chain 
reaction affects the permeability and fluidity of the neuronal plasma membrane. 
Damaged plasma membrane leads to undesirable effect on ion channels, receptors and 
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ion exchanger. Those adverse effects compromise of the neuronal cell death. There is 
a fatty aldehyde formation during lipid peroxidation, such aldehyde reacts with the 
thiol groups of some amino acids. The reaction between the amino acid of the protein 
and aldehyde disrupts the protein stability or even triggers protein denaturation. For 
the damage of DNA, oxidative stress brings about the breaking of double or single 
strand of DNA, the breaking the glycosylic bond between the base and ribose and the 
mispairing of purine and pyrimidine. Those alterations also compromise of the 
neuronal cell death (Henry et al., 1998). 
Actually, only little amount of free radical generated during the ischemia period. 
However, after the onset of reperfusion, reintroduction of oxygen leads to large 
amount of free radicals production. Free radical generation is not only due to lipid 
peroxidation, but also caused by nitric oxide synthase (NOS) activation, arachidonic 
acid metabolism and mitochondrial electron transportation (Henry et al., 1998). 
There are three types of NOS, neuronal NOS (nNOS), inducible NOS (iNOS) and 
endothelial NOS (eNOS). As mentioned before, the intracellular calcium level is 
increased during cerebral ischemia. Such elevation triggers the bind of calmodulin to 
nNOS and eNOS and activates these enzymes. For iNOS, unlike the former NOS, its 
regulation mainly depends on transcriptional level. The transcription is stimulated by 
cytokines. Those NOS convert the arginine and oxygen into citrulline and nitric oxide. 
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Nitric oxide will then react with superoxide to from peroxynitrite. The formation of 
peroxynitrite leads to several damaging process. For example, inactivation of calcium 
ATPase causes further increase of cytosolic calcium level and leads to cell death, 
damaging DNA and hence triggers apoptosis and initiating lipid peroxidation (Moro 
et al., 2004;Turley et al., 2005). 
For the arachidonic acid metabolism, large amount of glutamate release during 
cerebral stroke will overestimulate the NMDA receptor. This leads to elevated 
intracellular calcium level and activates phospholipase A2. Activated phospholipase 
A2 hydrolyzes the membrane phospholipids and liberates arachidonic acid. The 
further metabolism of arachidonic acid with lipooxygenase and cyclooxygenase gives 
out superoxide for the oxidative damages. Besides, the hydrolysis of cardiolipin, and 
inner mitochondrial phospholipids,\ by phospholipase A2 result in leakage of free 
radicals from mitochondria (Muralikrishna and Hatcher, 2006). 
Mitochondria are one of the major sources of free radical production during 
cerebral ischemia-reperfusion. In normal condition, ubiquinone will change into 
semiquinone and then dioJ at mitochondrial complex I and 11. However, hu^e amount 
influx of calcium inhibits complex I. Besides, nitric oxide can also enhance the 
formation of semiquinone. Hence, lots of free semiquinone is generated. When 
reperfusion occur，the reintroduction of oxygen allows the reaction between 
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semiquinone and oxygen with production of superoxide (Moro et al., 2005). 
1.9.6 Inflammation 
Inflammatory response occurs immediately after onset if ischemia lasts for a 
long time. Inflammation causes further damage of the brain after stroke and hence 
worsen the motor ability of the patient. Cell adhesion molecules and cytokines are 
responsible for the inflammatory response. One of the most important inflammatory 
mediators is nuclear factor KB (NF-KB). The inactivated form of N F - K B exists in 
cytosol and composed with three subunits, including p50, RelA and IKB. When under 
stimulation, IKB will be phosphorylated by kinase and then released. Afterwards, 
N F - K B translocates into nucleus and starts the transcription with its target gene 
including several adhesion molecules and cytokines. Besides, N F - K B can be activated 
by different stimuli, such as interIeukin-1 (IL-1), tumor necrosis factor (TNF) or even 
ischemia-reperfusion (O'Neill and Kaltschmidt, 1997). 
Several cytokines involves in the inflammatory response of cerebral stroke, such 
as IL-1 and TNFa. However, whether those cytokines are protective or invasive is 
controversial. It was reported that IL-1 and TNFa promote neuronal damaging in in 
vivo study. Both IL-1 and TNFa disrupt the integrity of the blood brain barrier and 
up-regulate the adhesion molecules for leukocyte rolling. Furthermore, TNFa can 
initiate apoptosis by binding to the FAS receptors while IL-1 can activate iNOS for 
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free radical production (Allan and Rothwell, 2001). 
Furthermore, infiltration of leukocytes allows further damage of the brain and 
increases the infarction. Infiltration of leukocytes into the ischemic territory requires 
binding of leukocytes to endothelial cells of the cerebral blood vessel. Such binding 
process called leukocyte rolling. Leukocyte rolling requires adhesion molecules, such 
as selectins, intercellular adhesion molecule (ICAM) and integrins. Selectins are 
expressed on endothelial cells and up-regulated by superoxide and cytokines. It 
interacts with leukocytes through the carbohydrate residue and enhances the 
infiltration of leukocytes. In addition, ICAM is also expressed on endothelial cells. 
Similar to selectin, it will be up-regulated by cytokines (IL-la and TNFa) during 
ischemia-reperfusion. ICAM tightly binds to the integrins which expressed on 
neutrophils and leads to migration of neutrophils into infarcted region in the brain. 
Unlike the previous adhesion molecules, integrins are expressed on leukocytes. 
Deprivation of oxygen stimulates the attachment between endothelial cells and 
neutrophils. As mentioned before, integrins bind to ICAM and lead to infiltration of 
neutrophils. The adverse effects caused by the migration of leukocytes are hindrance 
of micro-vessel and release of free radical and proteolytic enzyme (Huang et al., 
2006). 
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1.9.7 Apoptosis 
Apoptosis mostly occurs in the penumbra region of the ischemia brain. As 
mentioned before, TNFa produced during ischemia-reperfusion, the binding between 
TNFa and FAS-receptor triggers the extrinsic apoptosis pathway. This binding causes 
activation of caspase-8, and the activated caspase-8 cleaves pro-caspase-3 and 
activates it. Subsequently, caspase-3 further activates caspase-activated DNase (CAD) 
and initiates the cleavage of DNA. Also, cleavage of bid triggers cytochrome c release 
from mitochondria and its downstream apoptotic process. 
In addition, cerebral stroke does not only triggers the extrinsic apoptosis pathway 
but also the intrinsic one. Elevated level of cytosolic calcium, free radical and 
glutamate initiates the intrinsic apoptosis pathway. The translocation of the 
pro-apoptotic members of Bcl-2 family, such as bax and bad, from cytosol to 
mitochondria causes releasing of cytochrome c. Cytochrome c will then form a 
complex with Apaf-1 and procaspase-9, called apoptosome. Apoptosome activates 
caspase-3 for the subsequent apoptotic signaling cascade (Ferrer, 2006). 
1.10 Potential therapeutic agents for cerebral stroke 
1.10.1 Anti-oxidative enzyme and free radical scavengers 
Oxidative stress leads to cerebral infarction during and after stroke. Thus, 
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reducing the free radical production should reduce the brain damage. It was reported 
that up-regulation of anti-oxidative enzyme, such as superoxide dismutase (SOD), 
glutathione peroxidase (GPx) and catalase，reduced the brain infarct volume in in vivo 
model (Zhan and Yang, 2006; Luo et al., 2004; Wang et al., 2007a). 
SOD reduces the oxidative stress of the ischemia brain by breaking down the 
superoxide into hydrogen peroxide. There are two types of SOD found in the brain 
cells, copper, zinc-SOD (CuZn-SOD) and manganese-SOD (Mn-SOD). CuZn-SOD is 
a cytosolic enzyme and requires copper and zinc as co-factor while Mn-SOD is a 
mitochondrial enzyme and requires manganese to function (Chan, 1994). It was 
reported that CuZn-SOD can reduce the brain damage after cerebral 
ischemia-reperfusion. The brain infarct volume of CuZn-SOD knockout mice is 
higher than that of wild type mice after cerebral stroke (Kondo et al., 1997). Also, it 
could decrease the release of cytochrome c and bad translocation, and hence diminish 
apoptosis in penumbra (Saito et al., 2003; Paravicini et al., 2004). 
The functions of GPx in reducing the oxidative stress is changing the hydrogen 
peroxide that produced by SOD into water. There are five isoforais of GPx, GPx 1-5. 
GPx 1 is the most common one, it expresses in cytosol and in most tissues. GPx 2 and 
3 are mostly expressed in gastrointestinal tract and body fluid respectively. Moreover, 
GPx 4 is highly expressed in testis. GPx 1-4 are selenium-containing enzyme while 
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GPx 5 is not. It was reported that the brain infarction of GXpl knockout mice was 
two to three fold higher than that of the wild type in Middle cerebral artery occlusion 
(MCAo) model. Furthermore, the caspase 3 activation in the brain of GXpl knockout 
mice was accelerated after MCAo experiment (De Haan et al., 2003). 
Catalase can minimize the cerebral damage by converting the hydrogen peroxide 
into water and oxygen. It can be found in peroxisomes of almost all aerobic cells. 
Also, catalase is a common enzyme that exists almost in all organisms. According to 
previous study, over-expression of catalase could reduce the neuronal death after 
MCAo experiment in rat (Gu et al., 2004). 
Anti-oxidant can also potentially protect the brain injury during and after 
cerebral stroke. Ascorbic acid as an example, a well-known anti-oxidant, which can 
reduce the reactive oxygen species into water. It was reported that administration of 
oxidized form of ascorbic acid, dehydroascorbic acid (DHA), could significantly 
reduce the infarct volume in in vivo model. Since ascorbic acid is not favor in passing 
through the blood brain barrier, DHA was used instead. DHA passes through the 
blood brain barrier via GLUTl transporters and convert into ascorbic acid within the 
brain (Huang et al., 2001). 
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1.10.2 Ion channel blockers and glutamate antagonists 
In addition, interruption of the ionic homeostasis and of over-stimulation of 
glutamate receptor initiates downstream damaging pathway. Thus, ion channel 
blockers and glutamate antagonists may benefit to the stroked patients. The aim of 
using ion channel blockers and glutamate antagonists in treating stroke is to prevent 
the increase in intracellular calcium concentration. Several calcium channel blockers 
possess a protective property in cerebral stroke, including azelnidipine (Lukic-Panin 
et al., 2007)，nimodipine and isradipine (Sauter and Rudin, 1990). Limiting the influx 
of calcium reduces the free radical generation. Besides, excessive glutamate release 
causes over-stimulation of the glutamate transporters. Sodium channel blocker can 
inhibit the influx of sodium and hence, reduce the glutamate release. The reduction in 
brain infarction volume was observed when the rats were treated by BW619C89, a 
sodium channel blocker, after MCAo experiment (Graham et a l , 1994). Furthermore, 
glutamate antagonists can prevent excessive influx of calcium by blocking the 
interaction between glutamate and its receptors. It was reported that CP 101,606-27, a 
glutamate antagonist, could reduce the brain infarct in thromboembolic stroke model 
(Yang et al., 2003). 
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1.10.3 Anti-inflammatory agent 
Inflammation further damages the brain after ischemia-reperfusion, suppressing 
the inflammatory action maybe good to the patients. As mentioned above, leukocytes 
attachment is an important step in recruiting leukocytes into the infarcted area. Since a 
leukocyte rolling requires adhesion molecules, such as ICAM and selectins, 
suppression of those adhesion molecules could reduce the brain damage. The brain 
lesion sizes of ICAM-1 knockout mice were smaller than that of the wild type mice in 
MCAo model (Kitagawa et al., 1998). Besides, cytokines, like IL-1 and TNFa play an 
important role in cerebral stroke. A study showed that IL-1 (including IL-1 a and 
IL-1 p) knock-out mice exhibited a significant decrease in brain infarction after MCAo 
operation when compared with the wild type mice (Boutin et al., 2001). Also, the 
brain damage in IL-1 receptor antagonist (IL-lra) knockout mice after MCAo 
experiment is more serious than that of wild type mice (Pinteaux et al., 2006). Since 
inflammatory response further deteriorates the brain damage, inflammation 
suppression drug may benefit to patients. 
1.10.4 Anti-apoptotic agent 
Apoptosis induces neuronal cell death after ischemia-reperfusion in penumbra, 
hence, apoptosis inhibitors are potentially useful in treating stroke. Inhibition of the 
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pro-apoptotic members of Bcl-2 family or caspases can halt the apoptotic pathway. It 
was reported that inhibiting caspase 3 could reduce the brain infarct volume. 
Over-expression of p35, a pan-caspase inhibitor, significantly promoted the survival 
rate after MCAo operation (Sung et al., 2007). In addition, other anti-apoptotic 
compounds showed positive results in reducing neuronal cell death after stroke (Xiao 
et al., 2007; Ren et a l , 2007). 
1.11 Experimental model of cerebral ischemia-reperfusion 
1.11.1 In vitro model (oxygen and glucose deprivation model) 
Oxygen and glucose deprivation (OGD) model is a widely used in vivo model for 
mimicking the pathological conditions of ischemia-reperfusion. In humans, when the 
cerebral vessel occluded, the blood supply to the brain is halted. Then, both oxygen 
and glucose supplies are stopped. Thus, both oxygen and glucose are deprived in in 
vitro model to mimic the ischemic condition. For reperfusion, the blood reintroduce 
into the brain as the blood clots are dissolved or removed. Therefore, the 
reintroduction of oxygen and glucose will be done in OGD model to mimic 
reperfusion (Chang et al” 2008). Cell cultures or brain slices are usually employed in 
this model; neuronal cell death can be observed after OGD and reintroduction of 
oxygen and glucose. Although the in vitro model is less relevant than the in vivo 
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model, it gives preliminary result on drug screening. There are some drawbacks of 
using in vitro model in pathological study and drug screening. Blood brain barrier 
limits the movement of most molecules from the brain to the blood or vice versa. This 
limitation is due to the fact that brain endothelial cells are packed together as tight 
junction. However, molecules with a molecular weight smaller than 500, suitable lipid 
solubility or specific transporters can pass though the blood brain barrier (Ballabh et 
al., 2004). Since the drugs react with the cells directly in in vitro system, the 
efficiency of the drug in in vivo system cannot be truly reflected. For example, 
granulocyte/macrophage colony-stimulating factor showed neuroprotective activity in 
in vitro experiment. However, such neuroprotective effect could not be observed in in 
vivo ischemic gerbil model (Peng et al., 1998). Also, there is no blood flow in in vitro 
system. Thus, during reperfusion, there is no extra neutrophil bring into the ischemia 
insult. On the other hand, there are several advantages in using in vitro model to 
assess the effect of the potential drug. Firstly, most of the cerebral stroke mimicking 
in vivo model involves surgical procedures. Such surgical procedure contributes high 
degree of uneasiness and pain to the animal. Thus, in vitro model is a humane 
approach to examine the effect of the potential drug in the first step of study. Secondly, 
the control of experiment conditions in in vitro model is easier than that in animal 
model. Thirdly, in vitro experiment is less complicated than in vivo one. Hence, in 
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vitro can give an insight about the effect of the drug in a shorter period of time. Lastly, 
fewer resources (space, time and labour) are required in in vitro experiment. 
1.11.2 In vivo model (Middle cerebral artery occlusion) 
Middle cerebral artery occlusion (MCAo) is one of the most frequently used 
models to mimic ischemic reperfusion. Different kinds of animal can be employed in 
this experiment, such as mice, rat and gerbil. Intraluminal thread-occlusion method is 
commonly used in occluding the Middle cerebral artery (MCA) as it does not need 
complicated intracranial procedure and craniotomy. MCAo is induced by inserting a 
thread into internal carotid artery from external carotid artery, and then the thread will 
further place into the artery until blocking the origin of MCA. This MCAo experiment 
can consistently give an infarction in basal ganglia (Yanamoto et al., 2003). In 
addition, MCAo experiment can mimic temporary focal ischemia. The regional 
cerebral perfusion is dropped when the MCA is occluded and reperfusion is allowed 
by retracting the thread (Nagasawa and Kogure, 1989). Besides, this method can lead 
to cerebral infarction without causing death. Therefore, the animals can be further 
examined after they were stroked. 
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1.12 Traditional Chinese Medicine (TCM) 
1.12.1 General Introduction to Traditional Chinese Medicine 
Traditional Chinese Medicine (TCM) has been used for over several thousand 
years in China and other Asian countries. TCM is an integrated theory system which 
base on the human pharmacological information and experience. Moreover, the 
effectiveness of TCM is proven by clinical practice. There are several types of TCM 
such as herbal and animal medicine, Qi Gung, food therapy, acupuncture and remedial 
massage. Among the above treatment methods, herbal medicine is the most common 
method in healing. Herbal medicines are natural products and have fewer side effects 
than the synthesized drugs, so it draws more and more attention around the world. 
Although the effectiveness of TCM is quite promising and becomes one of the most 
important sources of alternative medicine, scientific prof of TCM is inadequate. 
Therefore, modernization of TCM is needed. Modernization of TCM means 
combining TCM with modem medicine and science. One of the important approaches 
to achieve this goal is using the scientific means to explore the mechanism of TCM in 
treating disease. Since herbal medicine is one of the important parts of TCM, 
standardization of the herbal product is essential in TCM modernization. Both good 
agricultural practice (GAP) and good manufacturing practice (GMP) are vital to 
increase the quality and the pharmaceutical value of the herbal medicine. 
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1.12.2 TCM and cerebral stroke 
The perspectives on stroke in Chinese and Western medicine are quite different. 
Western medicine focuses on pathology and aetiology of cerebral stroke. For TCM, 
stroke is regarded as wind stroke. Wind stroke is caused by five factors, including 
internal wind, external pathogenic wind, fire, phlegm and stagnation. The interaction 
between those factors may interrupt the balance of Yin and Yang, and the flow of 
blood and Qi. Such disruptions lead to the onset of wind stroke. There are two types 
of wind stroke, channel-collateral stroke and viscera stroke. The difference between 
these two types of stroke is that the patient with channel-collateral stroke remains 
consciousness while the patient with viscera stroke is not. In addition, 
channel-collateral stroke can be further divided into two different patterns, including 
invasion of wind pathogen and up-stirring of wind while viscera stroke can be divided 
into desertion stroke patterns and tension stroke patterns (Gong and Sucher, 2002). 
The basic theory for treating stroke is restoring the balance between the patient's 
resistance and the pathogenic factors. Therefore, the goals of treating wind stroke are 
enhancing the patient's resistance and reducing both internal and external pathogenic 
factors (Gong and Sucher, 2002). There are several commercially available TCM for 
treating stroke, for instance 'An Kung Niu Huang Wan' and "Mighty Qiangli Tianma 
Duzhong Capsule". 
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1.12.3 Chinese compound formula 
Herbal medicines are usually prescribed in a mixture of different herbs and based 
on the TCM theory. Compound formula consists of several herbs with certain ratio. 
There are several benefits in using compound formula. The first advantage is that 
different herbs can target different symptoms and prevent different complications. 
Therefore, the treatment is more comprehensive. Second advantage is that synergistic 
effect may occur between different herbs. Thus, the therapeutic efficacy can be 
promoted when using compound formula. Thirdly, prescribing compound formula 
reduces the dosage of single herb, hence, the toxicity of individual herb can be 
minimized (Gong and Sucher, 2002). 
1.12.4 Introduction to individual herb 
1.12.4.1 Radix Astragali (Pinyin name: Huangqi) 
Huangqi is usually prescribed as a dried root. According to TCM, Huangqi 
tonifies Qi and possesses of sweet and slightly warm properties. The major 
component are polysaccharides, saponins (Astragalosides I-VII) and flavonoids (Ma et 
al., 2002). For the properties that are related to stroke treatment, Huangqi possesses 
anti-oxidative and anti-inflammatory effects. It was reported that the crude extract of 
Huangqi could prevent lipid peroxidation that induced by copper in mice's brain 
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homogenate (Toda et al., 2000). Astragaloside IV, a compound from Huang Qi, could 
reduce the expression of E-selectin and the translocation of N F - K B in endothelial cells 
(Zhang et al., 2003). Besides, 20 mg/kg of Astragaloside IV could reduce the infarct 
volume by 30% in MCAo model (Luo et al., 2004). Based on the above evidences, 
Huangqi is a potential herb that can treat cerebral stroke. 
1.12.4.2 Rhizoma Chuanxiong (Pinyin name: Chuanxiong) 
Chuanxiong is one of the 50 fundamental herbs in TCM. Chuanxiong is 
commonly used in treating inflammation and cardiovascular diseases in China. Major 
active ingredients of Chungxiong are tetramethylpyrazine (TMP)，femlic acid, 
ligustilide and senkyunolide A. Z-ligustilide, purified from Chuanxiong could 
suppress the TNFa production in monocytes (Liu et al., 2005). Furthermore, TMP 
could reduce the cerebral injury in MCAo model by reducing the inflammatory action 
and anti-oxidative property (Liao et al., 2004; Hsiao et al., 2006). 
1.12.4.3 Radix Salviae Miltorrhizae (Pinyin name: Danshen) 
Danshen is usually prescribed as a dried root. According to TCM, the properties 
of Danshen are bitter and slightly cold. Danshen is one of the most common herbal 
medicines that are used in China. Different pharmaceutical dosage forms of Danshen 
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are commercially available in China. Based on TCM theory, Danshen can eliminate 
heat from blood, enhance blood flow and relieve blood stasis. The major active 
compounds that found in Danshen including Tanshinone I，Tanshinone IIA, 
Tanshinone IIB, Cryptotanshinone, Salvianic acid A, Salvianolic acid B and 
Protocatechualdehyde (Zhou et al., 2005). Danshen is effective in treating several 
diseases, for instance coronary heart disease, hepatitis, insomnia and cerebrovascular 
disease. There are numerous activities of Danshen which are benefit to cerebral 
patient, including anti-oxidation, anti-hypertension and anti-atherosclerosis. In the 
literature, both Tanshinone IIA and Tanshinone IIB could significantly reduce the 
brain infarct in in vivo murine model (Lam et al., 2003; Yu et al., 2007). 
1.12.4.4 Cassia Obtusifolia Linne (Pinyin name: Jue Ming Zi) 
The seeds of Cassia Obtusifolia Linne are usually used in TCM. Traditionally, 
Jue Ming Zi is used to treat eye inflammation and lacrimation. In addition, it was 
reported that scopolamine or transient bilateral common carotid artery occlusion 
induced memory and learning impairment could be reversed by treating with the seed 
of Cassia Obtusifolia Linne in in vivo model (Kim et al., 2007). Memory and learning 
impairment are common complications that occur in stroked patients, and Jue Ming Zi 
may help reversing these problems. Besides, Jue Ming Zi could scavenge 
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peroxynitrite (Park et al., 2004), this property can help reducing the oxidative stress 
during and after cerebral ischemia-reperfusion. 
1.12.4.5 Radix Glycyrrhizae (Pinyin name: Gancao) 
Again, Gancao is one of the 50 fundamental herbs used in TCM. According to 
TCM theory, Gancao can relieve pain and neutralize toxin. The major compounds of 
Gancao are glycyrrhizin, glycyrrhinic acid, glycyrrhetic acid, isoliquiritigenin, 
glycyamarin and glycyrol. The extract from Gancao could suppress 5-lipooxygenase 
(5-LOX) and cyclooxygenase-2 (COX-2) activities (Herold et al., 2003). Therefore, 
Gancao is potentially beneficial to the stroked patients. Also, isoliquiritigenin (ISL), a 
flavonoid constituent of Gancao, reduced the infarct volume by 86.5 mm^ in MCAo 
experiment (Zhan and Yang, 2006). 
1.12.4.6 Radix Angelicae Sinensiss (Pinyin name: Dong Quai) 
Danggui has analgesic, anti-inflammatory and sedative effects. Also, it can treat 
fatigue and reduce blood pressure. The properties of Danggui are sweet, acrid, bitter 
and warm. Z-ligustilide (LIG), a major lipophilic component of Danggui could reduce 
the infarct volume by about 10% with the dosage of 5 mg/kg. LIG reduced the level 
of malondialdehyde (MDA) significantly and enhanced GPx and SOD activity in the 
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ischemic brain. In addition, LIG inhibited the apoptotic pathway and hence minimized 
the brain damages of the mice in bilateral common carotid arteries occlusion model 
(Kuang et al., 2006). Besides, LIG treatment could significantly improve cognitive 
dysfunction that is induced by both common carotid arteries occlusion (2V0) (Kuang 
et al., 2008). Based on above evidence, Dong Quai may improve the performance of 
the patient during rehabilitation. 
1.12.4.7 Paeoniae Veitchii Radix (Pinyin name: Chi Shao) 
The properties of Chi Shao are bitter and slightly cold. It is usually prescribed as 
a dried root. Chi Shao is commonly used to treat fever, pain, inflammation and 
infection. Paeonol, a major component of Chi Shao, could reduce the brain infarction 
in MCAo model. Such reduction was due to the anti-inflammatory and anti-oxidative 
effect of paeonol (Hsieh et al., 2006). In addition, Chinese compound formula, 
Guizhi-Fuling-Capsules (GZFLC), which composes of Chi Shao could significantly 
reduce the brain infarction and suppressed the expression of IL-ip and TNFa in 
MCAo experiment. Such compound formula was administered by rats through 
intragastric administration (Li et al., 2007). 
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1.12.5 Salvianolic acid B 
Salvianolic acid B (SAB) is a polyphenolic acid and phenolic acids are the major 
hydrophilic components of Danshen. It was reported that SAB is an efficient radical 
scavenger and antioxidant. The anti-oxidative effect of SAB is even better than that of 
vitamin C (Zhao et al., 2008). Also, SAB could rescue neuroblastoma cells, PC 12, 
from hydrogen peroxide-inducing cell death (Liu et al., 2007a). SAB contains 
unsaturated rings and phenolic hydroxyl groups. These are the common features of 
anti-oxidant and these structures may contribute to the anti-oxidative activity of SAB. 
The following diagram shows the structure of SAB: 
OH j ^ O H 
h o A A ^ O ^ O Ah 
(Fig. 1.1 Chemical structure of Salvianolic acid B) 
Besides, SAB could inhibit ICAM expression on endothelial cells (Chen et al.’ 2001). 
This can inhibit the recruitment of leukocytes for further inflammatory damage. 
Furthermore, administration of SAB after MCAo experiment could reduce neuronal 
cell loss and improve of motor function of the animal (Tang et al., 2006). Therefore, 
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SAB is a potential drug in helping rehabilitation. 
1.13 Aim of study 
The aim of the present study was to examine the effects of Chinese compound 
formula, PSR and Salvianolic acid B (SAB) on post-stroke rehabilitation. The 
following approaches were used to reach the goal: 
i. To establish an in vitro oxygen glucose deprivation (OGD) model to mimic 
ischemia-reperfusion and to test the neuroprotective effect of PSR. 
ii. To establish Middle cerebral artery occlusion (MCAo) model to mimic stroke 
and to examine the neuroprotective effect of PSR and SAB in acute stage. 
iii. To perform a shuttle box escape experiment to evaluate the effects of PSR 
and SAB on memory retention and post-stroke depression. 
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Materials and Methods 
2.1 Materials 
2.1.1 Drug 
2.1.1.1 Herbal Medicine 
The Post-Stroke Rehabilitation herbal formula, PSR, was composed of seven 
herbal medicines, including Radix Angelicae Sinensiss, Radix Glycyrrhizae, Cassia 
Obtusifolia Linne, Radix Salviae Miltorrhizae, Rhizoma Chuanxiong, Radix Astragali 
and Paeoniae Veitchii Radix. The place of cultivation and the voucher number were 
shown in Table 2.1. Those herbal medicines were authenticated by Dr. Cao Hui 
(National Engineering Research Center for Modernization of TCM, Zhuhai, 
Guangdong, China) 
Table 2.1 Voucher number and the place of cultivation of the herbal medicines 
included in the Post-Stroke Rehabilitation herbal formal, PSR 
Single Herb Place of cultivation Voucher number 
Radix Astragali Inner Mongolia 2006-2959 
Rhizoma Chuanxiong Sichuan 2006-3002 
Radix Salviae Miltorrhizae Sichuan 2006-2957 
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Cassia Obtusifolia Linne Jiangsu 2006-2961 
Radix Glycyrrhizae Xinjiang 2006-2956 
Radix Angelicae Sinensiss Gansu 2006-2958 
Paeoniae Veitchii Radix Inner Mongolia 2006-2968 
2.1.1.2 Herbal extraction of PSR 
Raw herbs were cut into pieces with length, width and thickness being less than 
6 cm. The herbs were extracted under reflux with ten fold of water (w/v) for 1 hour. 
Afterward, the supernatant was collected and the residues were then undergone 1 hour 
extraction with eight fold of water for twice. The extracts were concentrated under 
reduced pressure (70�C，0.8-1.0 kPa) to form the paste (165 kg) with the concentration 
of 1.28 g/ml and then dried by heating. The extract powders were then taken to 
Cobalt-60 irradiation for sterilization. The yield was 17.7%. Thereafter, ethanol 
precipitation was performed. The extract powders were dissolved in distilled water in 
ratio of 2 : 1 (w : v). Then, 5 fold of absolute ethanol was added (Merck, Darmstadt, 
Germany) to adjust to 80% ethanol level and then the mixture was undergone 
precipitation overnight. After centrifuged at 3,000 x g for 15 minutes, the supernatant 
was collected and the ethanol was removed by using rotary evaporator. The yield was 
41.7%. 
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2.1.1.3 Herbal extraction of individual herb 
The herbs were cut into small pieces. Each single herb was extracted under 
reflux with ten fold of distilled water (w/v) for one hour. Afterward, the supernatant 
was collected and the residues were then undergone one hour extraction with ten folds 
of distilled water. Finally, supernatant were lyophilized to dryness. The yield of each 
herb was shown as follows: 
Table 2.2 The yield of different herbal medicines 
Single Herb Yield (%) Single Herb Yield (%) 
Radix Astragali 32.4 Rhizoma Chuanxiong 34.6 
Radix Salviae Miltorrhizae 50.0 Cassia Obtusifolia Linne 20.8 
Radix Glycyrrhizae 27.8 Radix Angelicae Sinensiss 53.2 
Paeoniae Veitchii Radix 28.4 
2.1.1.4 Salvianolic acid B with 99.12% purity was purchased from Topharman 
Shanghai Co., Ltd. (Pudong, Shanghai, China). Besides, Salvianolic acid B was also 
purified by Mr. Franky Choi (Institute of Chinese Medicine, The Chinese University 
of Hong Kong). One kilogram of sliced Salvia miltiorrhiza was refluxed with three 
liters of distilled water for one hour. The supernatant was collected and the residues 
were then undergone one hour extraction with three fold of distilled water. The 95% 
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ethanol was added. The mixture was equilibrated overnight and was then filtered. The 
supernatant was collected and the ethanol was removed by using rotary evaporator. 
The concentrated extract was lyophilized to dryness. The dried extract was applied to 
a macroporous resin D-101 column. The column was washed with distilled water to 
elute inorganic material and saccharide. The column was then washed with 50% 
methanol in order to obtain 2 fractions (F1 and F2). F2 was then chromatographed on 
a column of Sephadex LH-20 with 40% and 60% methanol. The eluent of 60% 
methanol contained Salvianolic acid B. HPLC was than performed to check the purity 
of Salvianolic acid B. The purity of Salvianolic acid B was found to be higher than 
90%. 
2.1.2 Chemicals 
2，2，-azobis(2-amidinopropance) dihydrochloride (AAPH) was purchased from 
Sigma (Saint Louis, MO, USA). Four hundred milimolar (400 mM) AAPH solution 
was prepared by adding 2.17 g AAPH granule in 20 ml PBS. The AAPH solution was 
freshly prepared before experiment and was prevented from light. 
2，3，5-TriphenyItetrazolium chloride (TTC) was purchased from Sigma. TTC 
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solution was prepared by dissolving 40 mg TTC powder in 20 ml PBS and stored at 
4 � C 
3-(4,5-dimethyIthizol-2-yl)-2,5-diphenyItetrazoIium bromide (MTT) was obtained 
from Sigma (Saint Louis, MO, USA). MTT solution (5 mg/ml) was prepared by 
dissolving 0.2 g MTT powder in 40 ml PBS. It was stored at 4 °C and in dark. 
Accelerator was purchased from Perimed AB (Stockholm, Sweden). 
AH trans retinoic acid was purchased from Sigma. All trans retinoic acid solution (20 
mM) was prepared by adding 8.32 ml DMSO (Sigma) in 50 mg all trans retinoic acid 
powder. It was stored at -20°C and in dark. 
Bicinchoninic acid solution (BCA) was purchased from Sigma (Saint Louis, MO, 
USA). 
Chloral hydrate was purchased from VER International Ltd (Poole, England). 
Chloral hydrate solution (175 mg/ml) was prepared by dissolving 3.5 g chloral 
hydrate powder in 20 ml saline. It was stored at room temperature. 
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Copper (II) sulphate pentahydrate (CUSO4 - 5H2O) (4% (w/v) solution) was 
purchased from Sigma (Saint Louis, MO, USA). 
Dulbecco's Modified Eagle Medium: Nutrient Mix F-12 (D-MEM/F12) was 
purchased from Invitrogen (Grand Island, NY, USA). DMEM/F12 solution was 
prepared by dissolving 15.6 g DMEM/F12 powder and 1.2 g Sodium bicarbonate 
(Sigma) in 1 L distilled water and the pH value was adjusted to 7.2. The medium was 
sterilized by filtration through 0.22 |Lim vacuum driven bottle top filter (Milipore, 
Bedford, MA, USA) under an aseptic condition. The medium was supplemented with 
10% (v/v) heat inactivated FBS, penicillin/streptomycin (100 U/ml; 100 ^ig/ml) and 
stored at 4 before use. 
Formalin solution, 10%, was purchased from Sigma (Saint Louis, MO，USA). 
Glucose free Dulbecco's Modified Eagle Medium (D-MEM) was purchased from 
Invitrogen. 
Fetal bovine serum (FBS) was purchased from Invitrogen (Grand Island, NY, USA). 
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Lysis buffer, pH 7.4，was composed of 2 mM magnesium chloride, 0.1 % Trition 
X-100 (Sigma) and buffered with Tris-HCl (Sigma), 0.002% protease inhibitor 
aprotinin (Sigma). 
Penicillin/streptomycin was purchased from Invitrogen (Grand Island, NY, USA). 
Phosphate-buffered saline (PBS), pH 7.4, was composed of 2.7 mM potassium 
chloride (KCl), 1.5 mM potassium phosphate (KH2PO4) (Sigma), 136 mM sodium 
chloride (NaCl) (Sigma) and 8 mM sodium dihydrogen phosphate (Na2HP04) 
(Sigma). 
Saline was prepared by dissolved 9 g sodium chloride in 1 L distilled water. 
Surgical glue (Loctite 4161 instant adhesive) was purchased from Perimed AB 
(Jarfalla, Sweden). 
All the reagents used in cell culture experiments were sterilized by manufacturers, 
filter-sterilized (0.22 j^m) or autoclaved before used. 
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All the surgical instruments used in animal experiment were sterilized by 75% ethanol 
before use. 
Assay Kits 
The Catalase Fluorometric Detection Kit was purchased from Assay Designs, Inc. 
(Michigan, USA) (Cat # 25-0607). 
The Glutathione Peroxidase (GPx) Assay Kit was purchased from Calbiochem 
(Gibbstown, NJ, USA) (Cat # 353919). 
The Superoxide Dismutase (SOD) Assay Kit - WST ((2-(4-Iodophenyl)-
3-(4-nitrophenyI)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt) was 
purchased from Dojindo Molecular Technologies, Inc. (Gaithersburg, MD，USA) (Cat 
#S311) 
2.1.3 Animals 
All the experimental procedures carried out in this study were performed in 
accordance with the guidelines approved by the Animal Ethics Committee of The 
Chinese University of Hong Kong. Male Sprague-Dawley (SD) rats weighing 
48 
Chapter 2 Materials and Methods 
195-200 g, 240-245 g and 300-310 g were purchased from Laboratory Animal 
Services Centre of The Chinese University of Hong Kong, Hong Kong, China. One 
SD rat was housed per cage with water and food ad libitum. All animals were housed 
in a room with temperature of 23 to 25 constant humidity and a 12-hour 
light-dark cycle. 
2.2 Methods 
2.2.1 (AAPH)- induced erythrocyte hemolysis 
A 300-310 g Sprague-Dawley (SD) rat was used in this experiment. The rat was 
first anesthetized by 1 ml chloral hydrate solution (175 mg/ml), and then the bloods 
were collected from abdominal aorta by using heparin containing evacuated blood 
collection tubes (BD，Franklin Lakes, NJ, USA). The RBCs were isolated from the 
heparinized blood by following procedures: the RBCs were first separated from 
plasma by centrifuging the blood by 1500 x g for 10 minutes. After removing the 
serum supernatant, the RBCs were washed by saline 2 times. Then the volume of 
collected RBC were measured and diluted into 20% RBC suspension by adding 4 
times volume of PBS. 
PSR and positive control (vitamin C) were weighed and dissolved in PBS. Then 
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various concentrations of samples were prepared by performing serial dilutions. Two 
hundred and fifty microlitres (250 ul) of 400 mM AAPH, 0.5 ml 20% RBC 
suspension and 0.25 ml sample was mixed to give 1 ml reaction mixture. The final 
concentrations of the samples were 31.25 |ig/ml, 62.5 |ig/nil, 125 |ag/ml, 250 |ag/ml, 
500 |j.g/ml and 1 mg/ml. For the negative control reaction, PBS was added instead of 
sample. The reaction mixtures were mixed by gently shaking and incubated at 37 
for 180 minutes with oscillation. 
Each incubated reaction mixture was undergone 20 fold dilution by adding 0.1 
ml sample with 1.9 ml PBS and 1.9 ml distilled water separately. Both reaction 
mixtures were mixed by gently shaking and then the RBCs were isolated by 
centrifugation at 1500 x g for 10 minutes. Two hundred microlitres (200 |il) 
supernatant was then transferred to flat bottom 96-well plate. Absorbance at 540 nm 
was measured. The percentage inhibition was calculated as follow: 
d H 2 0 s a m p l e _ P B S s a m p l e d E ^ O negative control 一 P B S negative control 
% Inhibition = - x 100 % 
d H s O s a n i p l e d H a O negative control 
50% inhibition concentration (IC 50) was measured in order to compare the 
anti-oxidative potency of the samples. 
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2.2.2 Cell Culture study 
2.2.2.1 Cell Line 
Human neuroblastoma cell line, SH-SY5Y 
SH-SY5Y cell line was derived from bone marrow of a patient with 
neuroblastoma. The cells were maintained in DMEM/F12 medium containing 10% 
(v/v) heat inactivated fetal bovine serum, penicillin/streptomycin 
(100 U/ml; 100 i^g/ml) in 75 cm^ tissue culture flasks and incubated in humidified 
95% air, 5% carbon dioxide at 37 SH-SY5Y cells grew as adherent cells. The 
medium was replenished every 3 days. 
Passage of cell line was carried out when the cell density reached 80% -
90% confluent. The cells were first washed by 2 ml PBS and then detached from the 
flask by incubating with 2 ml trypsin-EDTA solution in humidified 95% oxygen, 5% 
carbon dioxide at 37 °C for 5 minutes. The cells were then harvested and centrifuged 
at 1,000 X g for 3 minutes. After removing the supernatant, the cells were resuspended 
in 5 ml fresh medium. 500 i^l cell suspensions were seeded into 75-cm^ tissue culture 
flasks with 10 ml fresh complete medium. 
For long term storage of cell line, 80% - 90% confluent cells were washed by 2 
ml PBS and then detached by trypsinization. The cells were then harvested and 
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centrifiiged at 1000 x g for 3 minutes. After that, cell pellet was resuspended in 3 ml 
medium and the number of cells was counted by using a hemocytometer. The cells 
were then diluted into 1 x 10^ per ml medium (with 10% DMSO). 1-ml aliquots were 
then transferred into 2-ml cryogenic vials (Coming, NY, Canada). The cells were then 
kept at 4 °C for 1 hour and then cooled at -20 °C until frozen. After that, the cells were 
stored at -70 °C overnight and lastly stored in liquid nitrogen. To thaw cells, the frozen 
stock was thawed by incubating in 37 water bath and then transferred into a 75-cm^ 
tissue culture flask with 10 ml fresh complete medium. 24 hours later, the cells were 
adhered to the flask and the medium was replenished with fresh complete medium. 
2.2.2.2 Cell differentiation 
For cell differentiation, after the cells were detached from the flask, the number 
of cells was counted and then diluted into 14,400 cells per ml medium. 100卞 1 
aliquots of cell suspension were then seeded in a well of flat bottom 96-well plate. 
The cells were differentiated into neuron-like type by treatment with 10 \xM retinoic 
acid. 24 hours later, the cells were adhered to the flask and the medium was 
replenished with 100 i^l 10 |aM retinoic acid containing medium. The SH-SY5Y cells 
were undergone 5 days differentiation by incubating in 10 |.iM retinoic acid containing 
medium. The retinoic acid containing medium was replenished every 2 to 3 days. 
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2.2.2.3 In vitro model of ischemia - Oxygen glucose deprivation (OGD) 
experiment 
The OGD experiment used was achieved by maintaining the differentiated 
SH-SY5Y cells under oxygen-glucose deprivation for 1,2 and 4 hours, followed by 
24 hours of reperfusion. Firstly, the 10 )j.M retinoic acid containing medium was 
replaced with a glucose-free medium. Such glucose-free medium was deoxygenated 
by bubbling with an anaerobic gas mixture (95% nitrogen, 5% carbon dioxide) for at 
least 2 hours before use. The culture plates were then placed into an anaerobic 
chamber (Billups-Rothenberg, Inc., Del Mar, CA, USA) and flushed with the 
anaerobic gas mixture for 10 minutes. Afterwards, both inlet and outlet ports were 
fastened by closing the white plastic clamps and maintained at 37 °C for different 
periods of time. After a given time interval, the culture plates were taken out from the 
anaerobic chamber and the deoxygenated glucose-free medium was then replaced by 
fresh complete medium with various concentrations of PSR (0 ^ig/ml, 15.625 ^ig/ml, 
32.25 i^g/ml, 62.5 fig/ml, 125 fag/ml, 250 |_ig/ml, 500 \j.g/m\ and 1 mg/ml). The cells 
were undergone 24 hours reperfusion by incubating the culture plate in humidified 
95% air, 5% carbon dioxide at 37 
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2.2.2.4 Cell viability assay 
The relative cell viability was assessed by MTT assay. Thirty microliters of 5 mg/ml 
MTT solution was added into the medium and then incubated in humidified 95% air 
and 5% carbon dioxide at 37 for 4 hours. A well without any cell was assigned as 
blank. After 4 hours of incubation, the medium was discarded and 100 DMSO was 
added. Afterward, the culture plate was measured by Fluostar Optima Microplate 
Reader with absorbance at 540 nm.(BMG Labechnologies GmbH, Offenburg, 
Germany). The relative cell viability was expressed as the percentage of untreated 
control. 
2.2.3 In Vivo Study 
2.2.3.1 Cerebral blood flow (CBF) measurement 
Cerebral blood flow over the ischemic hemisphere was monitored via continuous 
laser Doppler flowmetry (PeriFlux System 5000, Perimed AB, Stockholm, Sweden). 
The 240-245 g male SD rat was first anesthetized by an intraperitoneal injection of 
0.6 ml chloral hydrate (175 mg/ml). After anesthetization, the scalp was sterilized by 
iodine and followed by 75% ethanol. Then the scalp was incised in the midline for 
about 10 mm and the skull was exposed. Thereafter, a small straight probe (PROBE 
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407-1, Peried AB) was positioned over the skull where 1 mm posterior and 2 mm 
lateral to Bregma using a miniature probe holder (PH 07-6, Perimed AB) fixed firmly 
to the skull with Loctite 4161 instant adhesive (Perimed AB) and accelerator (Perimed 
AB) (Spratt et al., 2006;Strbian et al” 2006). The CBF signal was measured from the 
same place throughout the Middle Cerebral Artery Occlusion (MCAo) experiment. 
2.2.3.2 In vivo transient focal cerebral ischemia model - Middle Cerebral Artery 
Occlusion (MCAo) 
Transient focal cerebral ischemia was induced by Longa's intraluminal filament 
rat model (Longa et al., 1989) with modification. After the beginning of measuring 
CBF and under the anaesthesia, hair near thoracic region of the rat was first removed 
and sterilized with iodine and 75% ethanol. About 2 cm cervical parasagittal incision 
where near the right common carotid artery (CCA) was made. Afterward, right CCA 
was exposed and isolated. A braided silk and waxed suture with size EP 1.5 (Pearsalls 
Limited, Taunto, Somerset, England) was placed across and below the right CCA; this 
could help stop bleeding by picking up the suture in case. Thereafter, the distal right 
external carotid artery (EGA), the branch vessel from EGA and the bridged vessel 
between EGA and internal carotid artery (ICA) were isolated and ligated by cautery 
(Gemini Cautery System, BIOSEB, Vitrolles, France). Then a braided silk and waxed 
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suture with size EP 1 (Pearsalls Limited) was placed across EGA for fixation of 
filament (diameter 0.26 mm). The CCA and distal ICA were then clamped transiently 
by micro bulldog clamp (World Precision Instruments Inc.，Sarasota, USA). A 
longitudinal incision was then made on EGA for the filament insertion. The filament 
was inserted from the opening on ECA into the lumen of ICA. Then the clamp on 
distal ICA was then released to allow further insertion of filament and also the suture 
which placed across ECA was then tied to prevent bleeding. After that, the filament 
was inserted for about 18 mm to 20 mm until the origin of middle cerebral artery 
(MCA) was occluded. Once the MCA was blocked, the CBF signal was dropped by 
about 60% and the CBF was monitored by laser doppler flowmetry (PeriFlux System 
5000, Perimed AB) throughout the experiment. After the blockage of MCA, the clamp 
on CCA was also released. A piece of cotton with saline was placed on the incision 
and the temperature was maintained around 26°C to 28°C during and after the 
experiment. The SD rat was undergone ischemia for 120 minutes. 0.1 ml of 175 
mg/ml choral hydrate was given to the anesthetized rat by intraperitoneal injection at 
1 hour after onset of ischemia in order to keep the rat under anesthetization. Two 
hours later, reperfusion was allowed by retracting the filament. Firstly, the cotton was 
removed and the CCA was then clamped transiently by micro bulldog clamp (World 
Precision Instruments Inc.). Then the tied suture on ECA was released to allow 
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retraction of the filament. After the filament was withdrawn from the lumen of ICA, 
distal ICA was clamped transiently by micro bulldog clamp (World Precision 
Instruments Inc.). Then the filament was retracted from EGA. The stump of ECA was 
tied up before releasing the clamps on ECA and distal ICA. Then the wound was 
sterilized by penicillin/streptomycin (10,000 U/ml; 10,000 |ig/ml). Afterwards, both 
incisions on scalp and neck were closed by using surgical needle (MANI Inc., Tochigi, 
Japan) with braided silk and waxed suture with size EP 1.5 (Pearsalls Limited). The 
anesthetized animal was placed in a single cage and the temperature was maintained 
at 26°C to 28°C. The stroked animals were undergone 24 hours reperflision. For the 
sham operation group, all the surgical procedures were the same as those carried out 
in control and treatment group except 2 hours MCA occlusion. 
2.2.3.3 Administration of PSR 
The clinical dosage of PSR was 0.1 g/kg. Such dosage was referenced to the 
recommended dose (individual herb) of the Chinese Pharmacopoeia and then 
reviewed and decided by the Chinese practitioners. To calculate the human equivalent 
doses of rat, it was obtained by dividing the human dosage by 0.162 (Center for Drug 
Evaluation and Research (CDER), 2005). One time HED of PSR used in the 
experiments was calculated as follows: 0.1 / 0.16 = 0.625 g/kg. PSR powder was first 
57 
Chapter 2 Materials and Methods 
dissolved in distilled water before administering to the rats. One time HED of PSR 
was prepared by dissolving 0.156 g of PSR powder in 1.4 ml of distilled water while 
ten times HED of PSR was prepared by dissolving 1.56 g of PSR powder in 1.4 ml of 
distilled water. For the single dose experiment, one time and ten times HED of PSR 
drug were given to the conscious rats orally, through an intragastric tube, at the 
second hour after the onset of reperfusion. 
I^CAO Drug administration 
Ischemia 
I < . 0 1 2 2 4 
N - — — — H hour 
-2 _ 一个 
Reperfusion 
Sacrifice 
Fig. 2.1 Schematic diagram of single dose experiment 
For the double doses experiment, one time, five times and ten times HED of PSR 
drug were given to the conscious rats orally，through an intragastric tube, at the first 
and second hour after the onset of reperfusion. 
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Fig. 2.2 Schematic diagram of double doses experiment 
1.4 ml distilled water was administered orally to the rats in control group. 
2.2.3.4 Administration of salvianolic acid B (SAB) 
Salvianolic acid B (SAB) was first dissolved in saline. For example, 10 mg/kg 
SAB solution was prepared by dissolving 2.4 mg SAB in 0.6 ml saline just before the 
experiment. The SAB was given to each rat right after the onset of reperfusion by 
intraperitoneal injection. 
I^CAO Drug administration 
Occlusion 士 
+ - 一 0 2 4 
• 2 < 
Reperfusion 
Sacrifice 
Fig. 2.3 Schematic diagram of SAB treatment experiment 
For the control group, 0.6 ml saline was administered instead. 
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2.2.3.5 Measurement of brain infarct volume 
Twenty-four hours after onset of reperfusion, the rats were sacrificed with 
overdose of chloral hydrate (1 ml of 175 mg/ml choral hydrate). Then each rat was 
decapitated and the brain was removed immediately. The brain was chilled in cool 
PBS and then placed at -20 for 120 minutes. After that, the brain was sliced into six 
serial coronal sections with 2 mm thick,starting at 2 mm from the frontal pole by 
using adult rat brain matrix (RBMA-300C, Kent Scientific Corp, Torrington, CT， 
USA) and sharp matrix blades (Kent Scientific Corp). Those six brain slices were then 
placed in 12-well plate and immersed in 2% TTC solution. The brain slices were then 
incubated at 37°C for 20 minutes. After staining with TTC, the brain slices were fixed 
by immersing in 10% phosphate-buffered formalin. After 24 hours, brain slices 
images were captured by a desktop scanner (hp Scanjet 3970, Hewlett-Packard 
Development Company, Palo Alto, CA, USA) with HP photo and imaging software 
version 2.1 (Hewlett-Packard Development Company) in following setting: 
Scale 100% Highlights 178 
Resolution 600 Shadows 4 
Sharpen level High Midtones 2.2 
Output format Tagged Image File 
The infarct area from the brain slices was then measured by using Adobe 
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Photoshop version 7.0 (Adobe Systems Incorporated, San Jose, CA, USA). 55,800 
pixels were equal to 1 cm^ of the brain slices. Total volume of the brain infarct was 
calculated as the total infarct area (5 brain slices at 4 mm, 6 mm, 8 mm, 10 mm and 
12 mm from the frontal pole) times the thickness of the brain slice (2 mm). The 
results were expressed as percentage of control. 
2.2.3.6 In vivo anti-oxidative enzyme activity determination in the brain 
2.2.3.6.1 Brain tissue preparation 
The rats were sacrificed with an overdose of chloral hydrate (1 ml of 175 mg/ml 
choral hydrate) after 24 hours of reperfusion. Then, the rats were decapitated and the 
brains were taken out. The brains were then washed by ice-cold PBS followed by 
quick frozen in liquid nitrogen. The brains were stored at -80 before use. 
2.2.3.6.2 Tissue homogenization and protein extraction 
The frozen brain was cut into 3 portions (A, B and C) (Fig. 2.4) and the right 
hemisphere of the brain (A) was collected. Afterward, the collected brain tissue was 
homogenized in ice cold PBS by using tissue grind pestle (Kontes, Vineland, New 
Jersey, USA). The homogenate was then centrifliged at 1,000 x g for 3 minutes and 
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then further washed by PBS twice. The supernatant was then discarded, and ice cold 
lysis buffer was added into the cell pellet. Equal volume of lysis buffer was added to 
the homogenate (w/v). 
The sample was then stored at 4 °C for 60 minutes and then freeze-thaw 
extraction were performed twice. For the freeze-thaw cycle, the sample was frozen by 
immersing in liquid nitrogen and then thawed at room temperature until the sample 
was completely melted. Then the sample was centrifuged at 10,500 x g for 20 minutes. 
After centrifugation, the supernatant was collected and aliquoted into several portions. 
The samples were stored at -80 °C before use. 
Fig. 2.4: The brain tissue was cut into three portions (A, B and C) and the right 
hemisphere of the brain (A) was collected 
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2.2.3.6.3 Protein concentration determination 
The protein amount of the samples was determined by Bicinchoninic acid 
solution (BCA) assay. Various concentrations (2 jag/ml, 4 ^ig/ml, 6 jig/ml，8 ^ig/ml, 10 
^g/ml) of bovine serum albumin (BSA) (Sigma) were employed as protein standards. 
Ten microliters (10 of protein standards were added into 96-well plate. For the 
samples, 1 )j.l sample and 9 |li1 PBS were added into 96-well plate. Ten microliters (10 
\il) PBS was used as a blank. Duplication of protein standards and samples were 
performed. Two hundreds microliters (200 |.il) BCA mixture solution (composed of 
BCA solution and Copper (II) sulphate pentahydrate (CuS04 - 5H20) in 50 : 1 ratio) 
was added into each well. The plate was then incubated at 37 °C for 30 minutes. The 
absorbance was measured at 540 nm. The protein concentration of sample was 
calculated from the standard curve using BSA as the protein standard.. 
2.2.3.6.4 Catalase activity determination in the brain 
The Catalase Fluorometric Detection Kit was purchased from Assay Designs, Inc. 
In this assay kit, the catalase activity was measured by detecting the amount of 
substrate (hydrogen peroxide) left after samples addition. Once the catalase 
containing sample was incubated with hydrogen peroxide, it was changed into oxygen 
and water by enzyme. In this experiment, 50 \i\ standards or samples were added into 
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96-well black plate and followed by adding 50 \i\ of 40 ^M hydrogen peroxide. 
40-fold dilutions of samples were used in this experiment. Catalase enzyme with 0.1 
U/ml, 0.05 U/ml 0.03, U/ml 0.02 U/ml, 0.01 U/ml and 0.005 U/ml activities were 
used as standard. Reaction buffer was added instead of sample in blank reaction. After 
incubating the reaction mixture at room temperature for 30 minutes, the non 
fluorescent detection reagent and horseradish peroxidase (HRP) were added into the 
reaction mixture. With the presence of leftover hydrogen peroxide, a fluorescent dye, 
resorufm, was produced. After 10 minutes incubation at room temperature, the 
samples were read by using Polarion Microplate Reader with Magellan software 
Version 3.11 (Tecan Group Ltd., Mannedorf, Switzerland) (excitation at 535 nm and 
emission at 595 nm). 
2.2.3.6.5 Glutathione Peroxidase (GPx) activity determination in the brain 
The Glutathione Peroxidase (GPx) Assay Kit was purchased from Calbiochem. 
In this assay kit, the GPx activity was measured indirectly by a coupled reaction 
which involving glutathione reductase (GR). Glutathione (GSH) was changed into 
oxidized glutathione (GSSG) when the hydroperoxide underwent reduction with the 
presence of GR. The GSSG was recycled to GSH by GPx and NADPH, and NADP+ 
was produced upon oxidation of NADPH. The reduction in the amount of NADPH 
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was measured at absorbance 340 nm. In this experiment, all the samples were 
undergone 10-fold dilution by the sample buffer which provided from the assay kit. 
GPx was used as a positive control while assay buffer (without containing any GPx) 
was used as blank. For the procedures, all the components except samples were 
pre-incubated at 25 °C for 10 minutes. 100 i^l assay buffer, 50 co-substrate mixture 
and 20 jil samples were added into 96-well plate. The reactions were then initiated by 
adding 20 |il of cumene hydroperoxide. The plate was shaken for 5 seconds and 
absorbance was measured every minute at 340 run (from zero to tenth minute) by 
Fluostar Optima Microplate Reader with Fluoster Optima software Version 1.30-0 
(BUG Labechnologies GmbH). 
2.2.3.6.6 The Superoxide Dismutase (SOD) activity determination in the brain 
The Superoxide Dismutase (SOD) Assay Kit - WST was purchased from 
Dojindo Molecular Technologies, Inc.. In this assay kit, water soluble formazan dye 
was produced when the Dojindo's highly water-soluble tetrazolium salt (WST-1) was 
reduced with superoxide anion. Superoxide anion was produced by converting 
xanthine and oxygen into hydrogen peroxide, uric acid and superoxide anion by 
xanthine oxidase (XO). As the superoxide anion was removed by SOD, there is a 
competition between SOD and WST-1. Thus, the SOD activity could be determined 
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indirectly by measuring the production of water soluble formazan dye at absorbance 
450 nm. For the procedures, 20 jil each of samples were added into sample wells and 
blank 2 well, 20 |al of dd H2O (double distilled water) was added into each blank 1 
and blank 3 well. Then, 200 i^l of WST working solution (containing WST-1) was 
added into each well and mixed. Afterward, 20 pi of dilution buffer to each blank 2 
and blank 3 well. Next, 20 [il of enzyme working solution (containing XO) was added 
into each sample and blank 1 well. After 20 minutes of incubation at 37 the plate 
was measured at absorbance 450 nm. The SOD activity was quantified as an 
inhibition activity by using the following equation: 
SOD activity (inhibition rate %)： [ (Abiank 1 - Ablank 3) - (Asample - Ablank 2)]丨(Ablank 1 一 Ablank 3) X 1 0 0 
2.2.3.7 Behavioral Evaluation 
2.2.3.7.1 Neurological behavioural test 
The neurological deficits were recorded at 24 hours after onset of reperfusion. 2 
observers blinded to identity of the treatment groups assessed the neurological status 
of the animals, by using a modified Bederson's scoring system (Bederson et al., 1986). 
Score 0 represents no apparent neurological deficits; Score 1 represents contralateral 
forelimb flexion; Score 2 represents decreased resistance to lateral push; Score 3 
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represents contralateral circling when pulling by tail; Score 4 represented spontaneous 
circling. 
2.2.3.7.2 Shuttle box escape experiment 
Experimental design 
In this experiment, the rats were randomly assigned to one of the five groups: 
Sham operation group; Control group; 5 times HED PSR treatment group, 10 times 
HED PSR treatment group and 40 mg.kg SAB treatment group. As shown in Fig. 2.5， 
3 days acclimatization was given to the rats from day -2 to day 0. Four consecutive 
days of training (day 1 to day 4) were then carried out in order to let the animals leam 
how to escape from the electic shock. Fifty shuttle trials were given to the animals 
each day during training series. MCAo was performed on day 4 after the last training 
session and followed by 6 consecutive days (day 4 to day 9) of treatment. For the 
testing series (day 8 to day 10), 50 shuttle trials were given to the animals each day. 
Also, neurological deficits were assessed by using a modified Bederson's scoring 
system (Bederson et al., 1986) during these three days. The rats were decapitated after 
the last testing session and TTC staining was performed to evaluate the brain infarct 
volume of the rats. 
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Fig. 2.5 Schematic diagram of shuttle box escape experiment protocol 
Acclimatization (Day -2 to Day 0) 
195 - 200 g male SD rats were allowed for 3 days acclimatization. One SD rat 
was housed per cage with free access to water and food. Those animals were housed 
in a room with temperature of 23 °C to 25 constant humidity and a 12-hour 
light-dark cycle. The rats were placed in a quite environment with minimal 
disturbance. 
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Training series (Day 1 to Day 4) 
The escape behaviour was evaluated by using automated two shuttle boxes (25 x 
25 X 27 cm per compartment) (Shuttle Boxes LE 916, Panlab s.L, Barcelona, Spain) 
equipped with shuttle box control unit (LE 900，Panlab s.L), shocker (LE 100-26, 
Panlab s.L) and controlled by Shutavoid version 1.80 (Panlab s.L)- Four training 
sessions were given to the rats during training series. In the beginning of each training 
session, single rat was placed in the shuttle box and allowed to habituate to the 
environment for 300 seconds and followed by 50 shuttle trials (Fig. 2.6). Thirty 
seconds intertrial interval was set between each shuttle trial. For each shuttle trial, the 
sound signal (92 dB) and the light signal were presented for maximum of 10 seconds 
duration. If the rat escaped to another compartment within these 10 seconds, it could 
prevent from receiving electric shock and this was counted as conditioned response. 
However, if the rat did not escape to another compartment within the first 10 seconds, 
electric shock (0.9 mA) was delivered to the rat through the static grids for maximum 
of 10 seconds duration. If the rat escaped from electric shock by shifting to another 
compartment, this was counted as unconditioned response. If the rat did not move to 
another compartment even under electric shock, this was counted as null response. 
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Fig. 2.6 Scheme diagram of each shuttle trial 
The response of the rat during the experiment was recorded by Shutvoid software 
automatically. The rat with over 50% conditioned response and with at least five 
consecutive conditioned responses in the last training session was selected for the 
experiment. 
MCAo and drug treatment (Day 4 to Day 9) 
On day 4, the successfully trained rats were then undergone MCAo with 2 hours 
ischemia. For the PSR treatment group, the drug was given to the conscious rat orally, 
through an intragastric tube, at the first and second hour after the onset of reperfusion. 
For SAB treatment group, SAB was given to the rat right after the onset of 
reperfusion by intraperitoneal injection. For the control group, water was given to the 
conscious rat orally, through an intragastric tube, at the first and second hour after the 
onset of reperfusion. From day 5 to day 9, single treatment was given to the rat each 
day. 
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Testing series (Day 7 to Day 9) 
Three training sessions were given to the rats during testing series. Again, single 
rat was placed in the shuttle box (Panlab s.l.) and allowed to habituate to the 
environment for 300 seconds. Fifty shuttle trials were given to rat each day and 30 
seconds intertrial interval was set between each shuttle trial. Neurological deficits 
were assessed after each testing session. The rats were decapitated after the last 
testing session (Day 9) and TTC staining was performed to evaluate the brain infarct 
volume of the rats. 
2.3 Statistical analyses 
Data were expressed as the mean 土 standard deviation (SD) in in vitro study and 
expressed as the mean 土 standard error of the mean (SEM) in in vivo study. Statistical 
analyses were performed by using GraphPad PRISM software version 5.00 
(GraphPad Software, San Diego, CA, US). Data were analyzed by one way analysis 
of variance (ANOVA) followed by Dunn's Multiple Comparison Test for 3 or more 
samples and analyzed by Mann-Whitney test for 2 samples. In all comparisons, P < 
0.05 was considered as statistically significant. 
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Chapter 3 
Results 
3.1 In vitro model of ischemia - Oxygen glucose and deprivation (OGD) 
experiment 
Oxygen and glucose deprivation (OGD) experiment was carried out to examine 
the neuroprotective effect of PSR on neuroblastoma cells under ischemia-reperfusion 
(Fig. 3.1). The differentiated SH-SY5Y cells were undergone different periods (1, 2 or 
4 hour) of OGD and followed by 24 hours of reperfusion. A serial, two-fold dilution 
was performed with the highest PSR concentration of 1,000 jug/ml. The wells without 
PSR served as control. The survival rate of the differentiation neuroblastoma cells 
were increased with increasing PSR concentration in both experiments. For 1 hour 
OGD experiment, the survival rates were increased from 107% 土 8.6% to 248% 土 
6.6% when the drug concentrations increased from 3.91 |ag/ml to 1,000 |j.g/ml. For 2 
hour OGD experiment, the survival rate was increased from 105% 土 4.2o/o to 198% 土 
7.3% when the drug concentration increased from 3.91 g/ml to 1,000 g/ml. For 4 hour 
OGD experiment, the survival rates increased to 156% 土 9.6% and 173% 土 13.7o/o 
when the concentrations of PSR were 500 |ag/ml and 1,000 |.ig/ml respectively. 
Besides, the survival rate was higher when the OGD period was shorter. For PSR 
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treatment group of 1,000 |ag/ml, the survival rates of 1, 2 and 4 hour OGD experiment 
were 248% 土 6.6o/o, 198% 土 7.3o/o and 173% 土 13.7% respectively. For PSR treatment 
group of 500 fig/ml, the survival rates of 1, 2 and 4 hour OGD experiment were 219% 
土 9.80/0, 185% 土 5.80/0 and 156% 土 9.6o/o respectively. All groups showed significant 
increase (P < 0.05) in survival rate when the concentration of PSR was higher than 
125 |ig/ml. In addition, the survival rate of 1 hour OGD experiment was significantly 
higher (P < 0.05) than that of 4 hour OGD experiment when the concentration of PSR 
was higher than 15.625 ^ig/ml. 
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Fig. 3.1 Oxygen and glucose deprivation (OGD) experiment on SH-SY5Y cells. 
SH-SY5Y cells were differentiated by adding 10 \xM retinoic acid. The differentiated 
cells were subjected to OGD for 1，2 and 4 hours followed by 24 hours of incubation 
with different concentrations of PSR. MTT assay was carried out to check the survival 
rate. Data are expressed as mean 土 SD, n = 5 samples. *p < 0.05 compared to the 
negative control within the same group by Dunn's Multiple Comparison; #P < 0.05 
compared to the 1-hour OGD group with same PSR concentration by Dunn 's Multiple 
Comparison. 
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3.2 AAPH assay of PSR 
AAPH assay was performed to check the free radical scavenging ability of PSR 
(Fig. 3.2). The highest concentration of PSR used was 1,000 |ag/ml with two-fold 
serial dilution. In addition, a well-known anti-oxidant, vitamin C，was employed as 
positive control. The data were expressed as percentage inhibition. The highest 
percentage inhibition of both vitamin C and PSR were around 80%. The percentage 
inhibition reached a plateau when the concentration of vitamin C and PSR were 125 
l^g/ml and 500 |_ig/ml respectively. The 50% inhibition concentration (IC50) of vitamin 
C and PSR were 32 fig/ml and 130 |j,g/ml respectively. 
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Fig 3.2 Inhibitory effects of PSR on AAPH-induced hemolysis of rat erythrocytes 
in vitro. Vitamin C was used as positive control. The IC50 of Vitamin C and PSR were 
about 32 |j.g/ml and 130 |ag/ml respectively. Data are expressed as mean 士 SD, n = 5 
samples. 
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3.3 AAPH assay of individual herbs 
AAPH assays of the following herbs, Radix Astragali, Rhizoma Chuanxiong, 
Radix Salviae Miltorrhizae, Cassia Obtusifolia Linne, Radix Glycyrrhizae, Radix 
Angelicae Sinensiss and Paeoniae Veitchii Radix, were carried out to examine the free 
radical scavenging ability of those herbs (Fig. 3.3a-g). The concentration of individual 
herb used was the same as that of PSR and Vitamin C was also used as a positive 
control. Among seven herbs, the IC50 of Salvia miltiorrhiza Bunge was the lowest. 
However, Radix Astragali and Radix Angelicae Sinensiss could not meet IC50 even 
with the highest concentration. Both herbs (except Radix Astragali and Radix 
Angelicae Sinensiss) could reach about 80% inhibition. For Salvia miltiorrhiza Bunge, 
the percentage inhibition reached plateau when its concentration was 250 |j.g/ml. The 
IC50 of Vitamin C, Rhizoma Chuanxiong, Radix Salviae Miltorrhizae, Cassia 
Obtusifolia Linne, Radix Glycyrrhizae and Paeoniae Veitchii Radix were about 32 
l^g/ml, 470 i^g/ml, 80 |ig/ml, 570 ^ig/ml, 360 ng/ml and 300 ^g/ml respectively. 
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AAPH assay of Cassia Obtusifoiia Linne 
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AAPH assay of Radix Paeoniae Veitchii 
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Fig 3.3a-g Inhibitory effects of the individual herb of PSR on AAPH-induced 
hemolysis of rat erythrocytes in vitro. Vitamin C was used as positive control. The 
IC50 of Vitamin C, Rhizoma Chuanxiong, Radix Salviae Miltorrhizae, Cassia 
Obtusifolia Linne, Radix Glycyrrhizae and Paeoniae Veitchii Radix were about 32 
Ug/ml, 470 i^g/ml, 80 ^ig/ml, 570 |ig/ml, 360 ^ig/ml and 300 ^ig/ml respectively. 
However, Radix Astragali and Radix Angelicae Sinensiss could not meet 50% 
inhibition. Data are expressed as mean ± SD, n =3 - 5 samples. 
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3.4 Brain slices after Middle cerebral artery occlusion (MCAo) experiment 
TCC staining was carried out to check if there was any brain infarction occurred 
in the rat. The brain was cut into 2 mm thick slice. Both sham-operated (Fig. 3.4a) and 
MCAo-operated (control group) (Fig. 3.4b) were performed. Four brain slices (4 mm, 
6 mm, 8 mm and 10 mm from the frontal pole) were stained in each group. There was 
no infarcted area observed in sham-operated rat in these brain slices. For the control 
group, infarction was clearly observed in these brain slices. However, the relative size 
of white area was decreased in the 10"�mm brain slice. 
81 
Chapter 3 Results 
mm mm 
Fig. 3.4a Brain slices from sham operation rat. Around 240 g male SD rat was 
undergone all the surgical procedures in MCAo experiment except occlusion of MCA 
for 2 hours. The brain was taken out 24 hours after the surgical procedures. Then the 
brain was cut into 2 mm slices and stained by TTC. The brain slices (from left to right) 
were 4 mm, 6 mm, 8 mm and 10 mm from the frontal pole. 
• • 藝 禱 
Fig. 3.4b Brain slices from control operation (MCAo operation only) rat. Around 
240 g male SD rat was undergone 2 hours ischemia and followed by 24 hour 
reperfusion. The brain was then cut into 2 mm slices and stained by TTC. The brain 
slices (from left to right) were 4 mm, 6 mm, 8 mm and 10 mm from the frontal pole. 
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3.5 Brain infarct volume of single dose protocol 
The brain infarction volume was expressed as percentage of control (Fig. 3.5). 
Three groups of rats were tested (Control, IX HED and lOX HED). Water was 
administered to the rats in control group. HED represents human equivalent dose. 
Rats in IX HED group were treated by 0.625 g/kg of PSR while rats in lOX HED 
group were treated by 6.25 g/kg PSR. Although there was a trend that increase the 
dosage could reduce the brain infarction volume, however there was no significant 
reduction in brain infarction in both IX HED and lOX HED treatment groups. The 
percentage control of brain infarction of IX HED and lOX HED treatment groups 
were 94.3% 土 4.47o/o and 87.4% 土 8.73% respectively. 
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Fig. 3.5 Brain infarction volume of single dose protocol. Sham group had no 
infarction measured. The animals (except for sham operation group) were undergone 
2-hour ischemia and followed by 24-hour reperfusion. Animals were sacrificed at 24 
hours after the onset of reperfusion and the brain infarction volume was detected by 
conventional TTC staining. IX HED and lOX HED groups were received with 1 time 
and 10 times human equivalent dose (HED) of post-stroke rehabilitation formula 
(PSR) respectively. Control group received water instead. Data are expressed as mean 
+/- SEM’ n = 9 - 10 samples. 
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3.6 Neurological behavioural test of single dose protocol 
Neurological behavioural test was performed to assess the severity of motor 
deficit of the animals (Fig. 3.6). Again, three groups of rats were tested, including 
Control, IX HED and lOX HED. Higher neurological score represents more serious 
of animals' motor deficit. The neurological scores of all the members in control group 
were 3. Although there was a trend that higher dosage of PSR could diminish the 
motor deficit of the animals, no significant decrease in neurological score could be 
observed in both IX HED and lOX HED groups. The neurological scores of IX HED 
and lOX HED were 2.67 土 0.33 and 2.20 土 0.58 respectively. 
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Fig. 3.6 Neurological score of animal in single dose protocol. Sham group had no 
scoring. Neurological score was assessed at 24 hours after reperfusion. IX HED and 
1 OX HED groups received with 1 time and 10 times human equivalent dose (HED) of 
post-stroke rehabilitation formula (PSR) respectively. Control group received water 
instead. Data are expressed as mean +/- SEM, n =5-10 samples. 
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3.7 Brain infarct volume of double doses protocol 
The brain infarction volume was expressed as percentage of control. Four groups 
of rats (Control, IX HED, 5X HED and lOX HED) have been tested (Fig. 3.7). The 
percentage control of infarction volume of IX HED, 5X HED and lOX HED were 
95.4% 土 7.240/0, 88.3% 土 8.65o/o and 74.5% 土 5‘43o/o respectively. All treated groups 
showed reduction in brain infarction. The brain infarction volume was significantly (P 
< 0.05) decreased when the rats were treated by lOX HED of PSR. 
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Fig. 3.7 Brain infarction volume of 2 doses protocol. Sham group had no infarction 
measured. Animals were sacrificed at 24 hours after reperfusion and the brain 
infarction volume was detected by conventional TTC staining. IX HED, 5X HED and 
lOX HED groups received 1 time, 5 times and 10 times human equivalent dose (HED) 
of post-stroke rehabilitation formula (PSR) respectively. Control group received water 
instead. Data are expressed as mean +/- SEM, n = 8 - 10 samples, *p < 0.05 by 
Dunn's Multiple Comparison Test. 
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3.8 Neurological behavioural test of double doses protocol 
The neurological behavioural test was used to assess the severity of motor deficit 
of the animals. Four different groups of rats were tested, including Control, IX HED, 
5X HED and lOX HED (Fig. 3.8). The neurological scores of all the animals in 
control group were consistently 3. The neurological scores of IX HED, 5X HED and 
lOX HED were 2.86 土 0.14, 2.14 土 0.46 and 2.15 土 0.30. The motor deficit was 
significantly relieved (P < 0.05) when the animals were treated by lOX HED of PSR. 
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Fig. 3.8 Neurological score of animal in 2 doses protocol. Sham group was not 
scored. Neurological score was assessed at 24 hours after reperfusion. IX HED, 5X 
HED and lOX HED groups received 1 time, 5 times and 10 times human equivalent 
dose (HED) of post-stroke rehabilitation formula (PSR) respectively. Control group 
received water instead. Data are expressed as mean +/- SEM, n = 7 - 13 samples, 
*p< 0.05 by Dunn's Multiple Comparison Test. 
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3.9 Determination of superoxide dismutase (SOD) activity in the brain 
Superoxide dismutase (SOD) activity in the brain was measured in different 
treatment groups (Fig. 3.9). The SOD activity of control group was significantly 
reduced (P<0.05) by 15.8% when compared with sham operation group. The SOD 
activity of lOX HED treatment group was significantly increased (P<0.05) when 
compared with control group. The specific SOD activity of control, 5X HED, lOX 
HED and sham operation groups were 10.9%/mg 土 0.46o/o/mg, 12.3%/mg 土 
0.35%/mg, 12.5%/mg 土 0.59o/o/mg and 12.9%/mg 土 0.19%/mg respectively. 
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Fig 3.9 Determination of superoxide dismutase (SOD) activity in the brain. SOD 
activity was expressed as inhibition rate (%) of WST-1 formazan formation. 5X HED 
and 1 OX HED groups received 5 time and 10 times human equivalent doses (HED) of 
post-stroke rehabilitation formula (PSR) respectively. Control group received water 
instead. Sham operation group underwent with all the surgical procedures in MCAo 
experiment except 2-hour ischemia and 24-hour reperfusion. Data are expression 
mean +/- SEM, n = 5 - 6 samples, *p< 0.05 by Dunn's Multiple Comparison Test. 
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3.10 Determination of glutathione peroxidase (GPx) activity in the brain 
Glutathione peroxidase (GPx) activity in the brain was measured in different 
treatment groups (Fig. 3.10). Although there was a trend that increasing the 
concentration of PSR could increase the GPx activity, there was no significant 
difference between different treatment groups. The specific GPx activity of control, 
5X HED, lOX HED and sham operation groups were 2.91 x 10"^  U/mg 土 7.6 x 10"^  
U/mg, 2.83 X 10-3 u/mg 土 2.9 x IQ-^U/mg, 2.99 x 10'^  U/mg 土 1.4 x 10"^  U/mg and 
3.01 X 10-3 U/mg 土 7.4 x 10"^  U/mg respectively. 
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Fig 3.10 Determination of glutathione peroxidase (GPx) activity in the brain. One 
unit of GPx activity represents that the amount of enzyme that oxidized 1.0 nmol of 
NADPH to NADP+ per minute at 25°C. The results were expressed as GPx activity 
per mini gram protein (U/mg). 5X HED and lOX HED groups were received 5 time 
and 10 times human equivalent doses (HED) of post-stroke rehabilitation formula 
(PSR) respectively. Control group received water instead. Sham operation group 
underwent with all the surgical procedures in MCAo experiment except 2-hour 
ischemia and 24-hour reperfusion. Data are expression mean +/- SEM, n = 5 - 6 
samples. 
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3.11 Determination of catalase activity in the brain 
The standard curve was plotted (Fig. 3.11a) in order to find out specific catalase 
activity in different treatment groups. The largest change in Resorufm (ARFU) was 
about 42,000 when the 0.1 U of catalase was added. ARFU reached plateau when 
0.05 U catalase was used. In addition, the cerebral catalase activity of different 
treatment groups was tested (Fig. 3.11b). Even there was a trend that increasing the 
concentration of PSR could increase the catalase activity, there was no significant 
difference between different treatment groups. The specific catalase activity of control, 
5X HED, lOX HED and sham operation groups were 0.0198 U/mg 土 5 x lO'^U/mg, 
0.0200 U/mg 土 7.2 x U/mg, 0.0200 U/mg ± 1.24 x U/mg and 0.0210 U/mg 土 
3 X 10"^  U/mg respectively. 
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Fig 3.11a Standard curve of catalase activity in the brain. One unit of catalase 
activity (U) would decompose 1.0 fimole of hydrogen peroxide per minute at pH 7.0 
and 25°C. The results were expressed as change in Resorufm (ARFU). The 
concentrations of catalase used in this test were 0 U, 0.005 U, 0.01 U, 0.02 U, 0.03 U, 
0.05 U and 0.1 U. 
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Fig 3.11b Determination of catalase activity in the brain. One unit of catalase 
activity (U) would decompose 1.0 |j,mole of hydrogen peroxide per minute at pH 7.0 
and 25°C. The results were expressed as catalase activity per one mini-gram protein 
(U/mg). 5X HED and lOX HED groups received 5 times and 10 times human 
equivalent dose (HED) of post-stroke rehabilitation formula (PSR) respectively. 
Control group received water instead. Sham operation group underwent with all the 
surgical procedures in MCAo experiment except 2-hour ischemia and 24-hour 
reperfusion. Data are expressed as mean +/- SEM, n = 5 - 6 samples. 
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3.12 Brain infarction volume of Salvianolic acid B (SAB) treatment 
The brain infarction volume was expressed as percentage of control (Fig. 3.12). 
Four groups of rats were tested (Control, 10 mg/kg SAB, 20 mg/kg SAB and 40 
mg/kg SAB). The percentage control of infarction volume of 10 mg/kg SAB, 20 
mg/kg SAB and 40 mg/kg SAB group were 82.9% 土 3.96o/o, 82.7% 土 3.43% and 
79.1% 土 2.67o/o respectively. Both treated groups showed reduction in brain infarction. 
However, only the rats which were treated by 40 mg/kg SAB showed a significant 
reduction (P < 0.05) in brain infarction volume. 
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Fig. 3.12 Brain infarction volume of Salvianolic acid B (SAB) treatment. Sham 
group had no infarction measured. The animals (except for sham operation group) 
undergo 2-hours ischemia and followed by 24-hour reperfusion. Animals were 
sacrificed at 24 hours after the onset reperfusion and the brain infarction volume was 
detected by conventional TTC staining. 10 mg/kg, 20 mg/kg and 40 mg/kg of SAB 
were injected to the rats intraperitoneally after the onset of reperfusion. Control group 
received saline instead. Data are expressed as mean +/- SEM, n = 6 - 7samples’ 
0.05 by Dunn's Multiple Comparison Test. 
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3.13 Neurological behavioural test of SAB treatment 
Neurological behavioural test was performed to assess the severity of motor 
deficit of the animals (Fig. 3.13). Higher neurological score represents more serious 
conditions of animals' motor deficit. The neurological scores of all the members in 
control group were 3. Although there was a decrease in neurological score in both 
SAB treatment group, no significant reduction could be observed. The neurological 
scores of 10 mg/kg SAB, 20 mg/kg SAB and 40 mg/kg SAB group were 2.57 土 0.37, 
2.33 土 0.33 and 2.43 土 0.37 respectively. 
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Fig. 3.13 Neurological scores of animal with SAB treatment. Sham group had no 
scoring. Neurological score was assessed at 24 hours after reperfusion. 10 mg/kg, 20 
mg/kg and 40 mg/kg of SAB were injected to the rats intraperitoneally after the onset 
of reperfusion. Control group received saline instead. Data are expressed as mean +/-
SEM, n = 6 - 7samples. 
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3.14 Shuttle box performance in training and testing series 
Shuttle box escape experiment was employed as behavioral test. During the 
training series, the percentages of conditioned response of different treatment group 
increased throughout the training series (Day 1 to Day 4) (Fig. 3.14). Moreover, all 
control, sham, 5X HED and 40 mg/kg SAB groups showed a statistically significant 
increase (P < 0.05) in the percentage conditioned response on the 3""�and day of 
training series when compared to the day. However, only the lOX HED treatment 
group showed significant increase (P < 0.05) in the percentage of conditioned 
response on day of training series when compared to the day. In addition, the 
performance between each group was similar (P > 0.05 by Dunn's Multiple 
Comparison Test) in the last day of training series. 
For the performance in testing series, both control, 5X HED and lOX HED 
groups showed a significant decrease (P < 0.05) in the percentage of condition 
response on the 1 ^ ^ day of testing series when compared to the last day of training 
series. On the other hand, both sham and 40 mg/kg SAB groups showed no significant 
decrease in the percentage of condition response between the first day of testing series 
to the last day of training series. 
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Fig. 3.14 Shuttle box performance (% avoidance) in training and testing series. All 
groups received MCAo at day 4 except sham group. The results were expressed as the 
percentage of conditioned response out of 50 trials. 5X HED and lOX HED group 
received 5 times and 10 times human equivalent dose (HED) of post-stroke rehabilitation 
formula (PSR) from day 4 to day 9 respectively. In addition, 40 mg/kg SAB group 
received 40 mg/kg of SAB from day 4 to day 9. Control and sham group received water 
instead. Data are expressed as mean +/- SEM, n = 6 - 11 samples. < 0.05 compared 
to the first day of the training series by Dunn's Multiple Comparison; #P < 0.05 
compared to the last day of training series by Dunn ’s Multiple Comparison. 
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3.15 Change in shuttle box performance (% avoidance c.f. last day of training) in 
testing series 
The performance of the rats during testing series were shown as the change in 
percentage avoidance comparing with last day of training (Fig. 3.15). The change in 
percentage avoidance of both lOX HED, 40 mg/kg SAB and sham groups on the 
day of testing series were significantly higher (P < 0.05) than that of control group. 
For the sham operation group, its change was significantly higher (P < 0.05) than that 
of control group in both days of testing series. 
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Fig 3.15a-c Change in shuttle box performance (% avoidance c.f. last day of 
training) in testing series. 5X HED and lOX HED groups received 5 times and 10 
times human equivalent dose (HED) of post-stroke rehabilitation formula (PSR) in the 
ist and the day of testing series. 40 mg/kg SAB group received 40 mg/kg of SAB 
and also, control and sham groups received water instead. The results were expressed 
as the change in percentage of conditioned response on the testing series compared 
with the last day of training series. Data are expressed as mean +/- SEM, n = 6 - 11 
samples. < 0.05, compared to the same day control by Dunn's Multiple 
Comparison. 
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3.16 Escape latency in testing and training series 
Escape latency was measured during shuttle box escape experiment (Fig. 3.16). 
Escape latency was defined as the time period from the start of unconditioned 
stimulus until escape. For the training series, there was no significant change in the 
escape latency in both groups, except for 40 mg/kg SAB treatment group. For the 
SAB treatment group, there was a significant decrease (P < 0.05) in latency time when 
comparing Day 1 to Day 4. Besides, there was no significant difference between each 
group on Day 4. 
For the performance in testing series, the escape latency of control group was 
significantly increased (P < 0.05) in all days of testing series when compared to the 
last day of training series. In addition, both 5X HED and 40 mg/kg SAB treatment 
groups showed significant increase (P < 0.05) in escape latency on the and 2"�day 
of testing series when compared to Day 4. Moreover, there was no significant change 
in escape latency between the days in testing series and the last day of training series 
in sham and 1 OX HED groups. 
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Fig. 3.16 Escape latency in testing and training series. Escape latency was defined as the time 
period from the start of unconditioned stimulus until escape. All groups received MCAo at day 4 
except for sham group. The results are expressed as latency time (s). 5X HED and lOX HED group 
received 5 times and 10 times human equivalent dose (HED) of post-stroke rehabilitation formula 
(PSR) from day 4 to day 9 respectively. 40 mg/kg SAB group received 40 mg/kg of SAB. Control 
and sham groups received water instead. Data are expressed as mean +/- SEM, n = 6 - 11 samples. 
*p < 0.05 compared to the first day of the training series by Dunn's Multiple Comparison; #P < 0.05 
compared to the last day of training series by Dunn 's Multiple Comparison. 
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3.17 Change in escape latency (c.f. last day of training) in testing series 
The escape latency during testing series was compared to the last day of training 
series (Fig. 3.17). The change in escape latency of sham operation group was 
significantly lower (P < 0.05) than that of control group in both days of testing series. 
Moreover, the change of lOX HED treatment group on the day of testing series 
was significantly lower (P < 0.05) than that of control group. 
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Fig 3.17a-c Change in escape latency (% avoidance c.f. last day of training) in 
testing series. 5X HED and lOX HED groups received 5 times and 10 times human 
equivalent dose (HED) of post-stroke rehabilitation (PSR) formula in the and the 
2nd day of testing series. 40 mg/kg SAB group received 40 mg/kg of SAB and also, 
control and sham groups received water instead. The results are expressed as the 
change in escape latency on the testing series compared with the last day of training 
series. Data are expressed as mean +/- SEM, n = 6 - 11 samples. < 0.05, compared 
to the same day control by Dunn's Multiple Comparison. 
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3.18 Brain infarct volume of shuttle box escape experiment 
The brain infarct volume was determined after the last session of testing series 
(Fig. 3.18). The percentage control of infarction volume of 5X HED, lOX HED and 
40 mg/kg SAB groups were 81.6 % 土 7.81o/o, 75.3 土 8.01o/o and 78.9% 土 6.46o/o 
respectively. There were significant reductions (P < 0.05) in brain infarct volume 
when the rats were treated with lOX HED of PSR and 40 mg/kg SAB. 
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Fig. 3.18 Brain infarct volume of shuttle box escape experiment. Sham group had 
no infarction detected. Animals were sacrificed at day 10 and the brain infarction 
volume was measured by conventional TTC staining. 5X HED and 1 OX HED groups 
received 5 times and 10 times human equivalent dose (HED) of post-stroke 
rehabilitation formula (PSR) from day 4 to day 9 respectively. Control and 40 mg/kg 
SAB group received water and 40 mg/kg SAB respectively. Data are expressed as 
mean +/- SEM, n = 6 - 11 samples. *p < 0.05, compared to the same day control by 
Dunn's Multiple Comparison. 
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3.19 Neurological score in shuttle box escape experiment 
The neurological scores were measured on Day 8 to Day 10 (Fig.3.19). There 
were significant improvement (P < 0.05) on the rats' motor function when they were 
treated with ten times HED of PSR on Day 9 and Day 10. The neurological scores of 
control and lOX HED groups on Day 9 were 2.73 土 0.19 and 1.38 土 0.32 respectively. 
In addition, the neurological scores of control and 1 OX HED groups on Day 10 were 
2.45 土 0.16 and 1.00 土 0.33 respectively. 
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Fig. 3.19 a-c Neurological score in shuttle box escape experiment. Neurological 
score of animal in shuttle box experiment. Neurological score was assessed at days of 
testing series (i.e. Days 8-10). 5X HED and lOX HED groups received 5 times and 10 
times human equivalent dose (HED) of post-stroke rehabilitation formula (PSR) from 
day 4 to day 9 respectively. Control and 40 mg/kg SAB groups received water and 40 
mg/kg SAB respectively. Data are expressed as mean +/- SEM, n = 6 - 11 samples. 
< 0.05, compared to the same day control by Dunn's Multiple Comparison. 
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Chapter 4 
Discussion 
4.1 The protective effect of PSR in in vitro oxygen and glucose deprivation (OGD) 
on human neuroblastoma SH-SY5Y cell line 
4.1.1 OGD model and cell line 
The oxygen and glucose deprivation model was first developed by Goldberg and 
Choi (1993). OGD experiment could mimic the acute restriction of glucose and 
oxygen supply that caused by ischemia and showed that the resulting neuronal death 
had similarity of cerebral neuronal death (Wang et al., 2002). Since this is a simple in 
vitro model of the in vivo ischemia-reperfusion insult, it has been extensively used in 
exploring cellular mechanisms during ischemia or searching for the potential drugs 
(Serra-Perez et al , 2008;Wang et a l , 2002;Miglio et al., 2004). Actually, in the 
literature review, primary neuronal cell cultures are also frequently employed in OGD 
experiments. However, the drawback of using primary neuronal cell cultures is that 
the cell vulnerability is affected by several factors including cell types, cell density, 
medium and purity (Miglio et al., 2004). Thus, a SH-SY5Y human neuroblastoma cell 
line was used instead. 
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The SH-SY5Y cell line was used in OGD experiment as it is sensitive to 
oxidative stress and has glutamate receptors. In view of the fact that oxidative stress 
and excitotoxity are the major sources of the ischemia insult, using this neuroblastoma 
cell line could have a better response to ischemia-reperfusion (Miglio et al., 2004). 
The SH-SY5Y human neuroblastoma cell line can be differentiated morphologically 
and biochemically into more neuronal-like phenotype by treating cells with 10 |J,M 
retinoic acid for 5 days (Serra-Perez et al , 2008). The undifferentiated cells were 
rounded shape and slightly elongated. Also, short and highly branched processes are 
emanating from the cell body of undifferentiated cells. For the differentiated cells, 
their cell bodies become more rounded and have fewer branches but long thin neurites 
(Brown et al., 2005). Differentiated cells were used instead of the undifferentiated one, 
because the undifferentiated tumour cells cannot control their proliferation rate and 
have anti-apoptotic property (Miglio et al., 2004). Those properties are less vulnerable 
to the ischemia damage. Therefore, differentiation was carried out in order to have 
better understanding of the protective effects of PSR in ischemia-reperfusion damage. 
4.1.2 Protective effect of PSR in OGD experiment 
Neuronal cell death can be caused by OGD experiment followed by reperfusion, 
longer the OGD incubation time, the higher the mortality rate of cells (Miglio et al., 
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2004). Actually, necrosis is the major cause of cell death during OGD and apoptosis 
becomes more abundant after the onset of reperfusion (Fordel et al., 2007). The OGD 
experiment data (Fig. 3.1) showed that the survival rate was higher when the OGD 
period was shorter. The survival rate of 1-hour OGD experiment is significantly (P < 
0.05) higher that of 4-hour OGD experiment when the concentration of PSR is higher 
than 15.63 ^ig/ml. It represents that more cells can be saved if the ischemia period is 
shorter. As mentioned before, necrosis is the major cause of cell death during OGD 
period. More cells suffer from irreversible necrotic cell death when the OGD period is 
longer, thus, less cells can be saved in 4-hour OGD experiment compared to 1 -hour 
OGD experiments. However, the survival rate between 1 -hour and 2-hour OGD 
experiment did not have significant difference. It suggests that there was no extensive 
necrotic cell death within the first and the second hour of OGD period. 
Furthermore, a dose dependent manner was observed when the concentration of 
PSR was higher than 125 )j.g/ml. There were significant increases in survival rate 
when PSR concentrations used were higher than 125 |ag/ml in both experiments. It 
means that PSR could rescue the cells from ischemia-reperfusion damage. For the 
OGD experiment, besides necrosis and apoptosis, free radical production is one of the 
major damaging processes followed by ischemia and reperfusion (Abramov et al., 
2007; Cimarosti et al., 2005). It was reported that the hydrogen peroxide level was 
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significantly increased when the SH-SY5Y cells underwent OGD and reperfusion 
(Fordel et al., 2007). In addition, the drug with anti-oxidative property could reduce 
the free radical accumulation, and hence reduced the lipid peroxidation and cell death 
(Miglio et al., 2004). One of the possible reasons why PSR reduce the 
ischemia-reperfusion insult is due to its free radical scavenging ability. 
4.1.3 Free radical scavenging property of PSR 
AAPH assay was carried out (Fig. 3.2) to test the free radical scavenging ability 
of PSR, and the result showed that the IC50 of PSR in this assay was 130 |^ g/mL 
Erythrocytes were used in this assay. AAPH generates free radicals which will then 
attack the erythrocyte membrane and causing lipid peroxidation, and hence, hemolysis 
(Shiva et al., 2007). If the drugs possess a free radical scavenging property, hemolysis 
could be inhibited. Actually, AAPH assay can give an insight about the protective 
effects of the drugs in OGD experiment, as free radical scavenging property could 
protect the cells from OGD inducing neuronal cell death (Rawal et al.’ 2004). In 
addition, vitamin C, a well-known non-enzymatic scavenger of free radicals, was 
employed as positive control. The IC50 of vitamin C was 32 |ag/mL The anti-oxidative 
property of vitamin C protected the brain damages in a primate ischemia-reperfusion 
model (Henry and Chandy，1998). Although, the IC50 of PSR was about 4 folds higher 
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than that of vitamin C, both of them could maximally reach about 80% inhibition. 
Therefore, the protective effect of PSR showed in OGD experiment may due to its 
free radical scavenging ability. 
4.2 The protective effects of PSR in in vivo middle cerebral artery (MCAo) model 
4.2.1 The shortcomings of in vitro OGD model 
The results obtained from in vitro model cannot fully reflect neuroprotective 
ability of PSR in in vivo environment. Actually, there are many different cell types 
which could be found in brain including, astrocytes, microglia, neurons and 
endothelial cells. All of them can affect the extent of the brain injury caused by 
inschemia-reperfusion (Kim et al., 2004). However, only human neuroblastoma cells 
were used in OGD experiment and hence the effect of the drug toward different cell 
types could not be determined. Besides, one of the major hindrances of the stroke 
treatment is blood brain barrier. Since the brain endothelial cells are packed together 
through tight junctions, then restrict the movement of most molecules from the blood 
to the brain or vice versa. Such property may block the neuroprotective effect of the 
potential drug, and one of the examples is Brain-Derived Neurotrophic Factor 
(BDNF). BDNF is neuroprotective in regional brain ischemia. However, it cannot 
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pass the blood brain barrier. Therefore, direct intra-cerebral administration of BDNF 
is needed instead of intravenous administration (Zhang and Pardridge, 2006). 
Moreover, extra neutrophils will go to the ischemia insult through reperfusion and 
causing further cerebral damage. However, there is no blood circulation in in vitro 
model and the potential anti-inflammatory effect of the drug could not be evaluated. 
4.2.2 Development of in vivo MCAo model and TTC staining 
Due to the above reasons, in vivo experiment was carried out to test the effects of 
PSR in physiological situation. Since focal ischemia is the most common type of 
cerebral stroke and causing long term disability, an in vivo model that mimicking 
focal ischemia was chosen. Animal focal ischemia model is similar to human cerebral 
stroke, and the ischemia insult can be produced by the occlusion of the MCA (Longa 
et al., 1989). An intraluminal thread-occlusion technique targeting the MCA was used 
as it does not require complicated intracranial procedures and allows reperfusion by 
retracting the thread. A reversible regional cerebral ischemia insult (Penumbra) can be 
produced in this model and no inhomogeneous blood flow occurred during 
recirculation (Nagasawa and Kogure, 1989). Both infarct core and penumbra can be 
found after 2-hour MCAo and 24-hour reperfusion, and the reduction in cerebral 
blood flow in these areas is constant throughout 120-minute MCAo (Ashwal et al., 
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1998). Laser-Doppler flowmetry was employed in MCAo experiment, the probe was 
placed over the skull at 1 mm posterior and 2 mm lateral to Bregma. Since the blood 
supply within this region is supplied by MCA, the CBF in this region reflects the 
status of MCA (Spratt et al., 2006). The brain slices of the rat underwent 2-hour 
MCAo and 24-hour reperfusion were shown in Fig. 3.4b. There was a large infarct 
area showed in cortex, striatum and hippocampus. 
TTC staining was employed to evaluate the infarct area of the brain. The brain 
was cut into 2 mm slices. The infarct area of five brain slices, 4 mm from the frontal 
pole, was measured. Actually, these five brain slices covered all the infarct territory of 
the brain. TTC is one of the most frequently employed histochemical staining 
methods for identifying of infarcted tissue. TTC staining relies on the oxidation of 
TTC by intact mitochondrial dehydrogenase. Since infarcted tissue is lack of 
dehydrogenase activity, such area cannot be stained and remains white. While the 
intact tissue contains mitochondrial dehydrogenase, it will be stained and formed the 
carmin red product, formazan (Schilichting et al., 2004). 20 minutes incubation at 
30°C is enough for formazan formation (Fig. 3.4a). One of the advantages of using 
TTC staining method to determine the infarct area is that the infarcted area can be 
easily discerned from the intact tissue since the contrast between infarcted and normal 
tissue is high (Schilichting et al., 2004). In the MCAo experiment, stroke was 
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successfully induced by 2-hour MCA occlusion and 24-hour reperfusion as white area 
was shown in right hemisphere in Fig. 3.4b (Gerriets et al.，2004). Also, since the 
MCA was no occluded in sham operation rat, not white area has been observed (Fig. 
3.4a). 
4.2.3 Protective effect of PSR in MCAo experiment (single dose protocol) 
The brain infarct volume was determined after 2-hour ischemia followed by 
24-hour reperfusion in order to evaluate the protective effect of the PSR in acute 
phase (Lee et al., 2006; Zhan and Yang，2006). The effects of PSR on acute phase 
were first tested because the drugs which exhibited a protective effect in acute phase 
should also show a curing effect in chronic phase and have better performance in 
behavioral test (Xiao et al., 2005). Therefore, brain infarction evaluation on acute 
phase could give an insight about the effects of PSR during chronic phase, and hence 
rehabilitation. The size of infarct area is positively correlated with the severity of the 
brain damage, and the percentage control of brain infarct volumes of single dose 
protocol were shown in Fig. 3.5. PSR was given to the treatment group at the 2'化 hour 
of reperfusion. Oral administration was chosen instead of intraperitoneal injection or 
intravenous injection because compound formula of TCM is traditionally consumed 
by oral administration. Also, since compound formula composes of different herbs 
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and its constituents cannot be fully determined, it is dangerous to have an intravenous 
injection. In addition, as the volume of the drug is large, intraperitoneal injection or 
intravenous injection are not feasible in this case. For the result, no significant 
decrease in brain infarct could be observed in both treatment groups. The failure in 
cerebral protection due to several reasons; firstly, the drug may not possess 
neuroprotective effect in physiological environment. Second，the dosage may not high 
enough to therapeutic window. Thirdly, the time of treatment may limit the protective 
effect of the drug. However, since positive effect was obtained in in vitro study and 
the herbs used could protect the brain from ischemia-reperfusion injury (refer to 
Chapter 1.11), it was believed that PSR is effective in neuroprotection. Therefore, the 
single dose protocol was changed in order to increase the effectiveness of PSR. 
4.2.4 Protective effect of PSR in MCAo experiment (double doses protocol) 
Double dose protocol was then performed instead of single dose. The ways to 
increase the effectiveness of the drug include increasing the dosage (Zhan and Yang， 
2006; Lee et al., 2006) and shortening time between drug administration and the onset 
of reperfusion (Tang et al., 2007). Accordingly, the time of drug administration was 
shortened into one hour after the onset of reperfusion and the two times of dose of 
drug were given to the rats instead of one dose. Finally, a significant decrease in brain 
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infarct volume was observed when the stroke rats treated by ten times HED of PSR at 
the pt and hour of reperfusion (Fig. 3.7). The brain infarct decreased by about 
25% when treated with ten times HED of PSR. This positive result further confirmed 
that PSR could protect the brain from ischemia-reperfusion damage, and such 
protective effect was not only shown in in vitro system, but also the in vivo 
environment. The significant decrease in brain infarction also gives an insight that 
PSR may facilitate rehabilitation. The effectiveness of PSR has been improved in 
double doses protocol since the dosage was increased and shortening the treatment 
time. More effective compounds could reach the brain when the dosage increased, 
hence, better protective effect could be observed. Also, since huge amount of free 
radical production was produced once reperfusion started, earlier treatment could 
reduce such damage. 
In the literature, the brain infarct reductions in post-treatment were ranged from 
about 20% to 35%. The neuroprotective of drug is time-dependent, the protective 
effect in pre-treatment experiment is better than that of post-treatment experiment (Yu 
et al., 2005; Wang et al., 2007b; Tang et al., 2007; Xiao et al., 2005). Such 
phenomenon may due to the infarct core was formed during ischemia. Since the 
damage within infarct core is irreversible，the neuroprotective of the drug will be 
limited if it is administered after the ischemia period. 
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4.2.5 The effect of PSR toward neurological deficits 
Since one of the most frequent complications of cerebral stroke is neurological 
deficit, neurological examination was carried out as described by Bederson et al. 
(1986). In order to evaluate the motor deficits between different groups, the motor 
deficits are detected more consistently when using a specific test rather than just 
observation of the rats' activity. Transient occlusion of the MCA could cause damage 
and death of cerebral cells in cortex and striatum and then led to motor dysfunction 
(Tang et al., 2007). For the control group, since infarction could be found in cortex 
and stratum (Fig. 3.4b)，motor deficits could be observed. Also, all rats in control 
group showed several neurological symptoms including contralateral forelimb flexion， 
decreased resistance to lateral push and contralateral circling when pulling by tail was 
observed in control group. This means the neurological deficits induced by MCAo 
were quite consistent. Furthermore, the severity of the motor deficits is correlated 
with the size of brain infarct (Bederson et al., 1986). Thus, the results of neurological 
examination (Fig. 3.8) were consistent with the results of histopathological 
examination in PSR treatment. As mentioned before, the rats treated with ten times 
HED of PSR with double doses protocol showed significant decrease in brain 
infarction (Fig. 3.7), hence, there was a significant improvement of the motor deficits 
in this group of rats (lOX HED). Since one of the major goals of stroke rehabilitation 
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is helping disabled stroke patient returns to normal life, better motor functions let the 
patients perform their daily living activity more easily. Interestingly, there was a 
significant decrease in brain infarction in 40 mg/kg SAB treatment group (Fig. 3.12) 
but no significant improvement in motor function (Fig. 3.13). This may due to the 
reduction in brain infarction was not large enough to have a significant improvement 
in motor function. 
4.2.6 Anti-oxidative effects of PSR in MCAo model 
Cerebral ischemia-reperfusion is accompanied by formation of reactive oxygen 
radicals, for example superoxide anion, hydrogen peroxide and hydroxyl radical with 
the ischemia insult. Huge amount of free radicals are generated during reperfusion 
because of sudden resupply of glucose and oxygen to neurons that cannot be utilized 
by the mitochondria as under normal physiological conditions. Hence, the incomplete 
reduction of oxygen by the mitochondria favors the formation of free radicals (Yu et 
al” 2008). Free radicals cause several adverse effects, including damaging the lipids, 
protein and nucleic acids and eventually led to neuronal cell death. However, such 
free radicals could be scavenged by several endogenous anti-oxidative enzymes, such 
as SOD, GPx and catalase. The amount of free radicals could be reduced by these 
enzymes and hence, reducing the brain damage. In the literature, some herbs included 
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in PSR could increase the activities of anti-oxidative enzymes. For example, 
Z-ligustilide (LIG) which was isolated from Radix Angelicae Sinensiss could increase 
the activities of SOD and GPx in the brain of the stroked mice (Kuang et al , 2006), 
also Salvia miltiorrhiza could enhance the liver SOD activity after hepatic 
ischemia/reperfusion injury (Xing et al., 2005). Therefore, the effect of PSR on the 
activities of these anti-oxidatvie enzymes was tested. 
Actually, the activities anti-oxidative enzymes are reduced after cerebral 
ischemia-reperfusion injury (Yu et al., 2008). These results were also confirmed in our 
experiments. There was a significant decrease in SOD activity (Fig. 3.9) when 
comparing control group to sham operation group, and it indicates the presence of a 
marked oxidative stress. The reduction in SOD activity may result from an attack of 
free radicals to the active site of SOD or consumption of anti-oxidative enzyme by the 
free radicals (Zhang et al., 2007). However, the activities of GPx and catalase between 
control group and sham operation group had no significant difference. Actually, there 
was a decrease in GPx and catalase activities in control group, however, the 
sensitivity of the assay kits may not high enough to show the difference between each 
group. Therefore, no statistical difference could be found between different groups of 
GPx and catalase activities. In fact, only the brain tissue of the ischemic hemisphere 
was taken out for assaying the activities of the anti-oxidative enzymes (Zhan and 
129 
Chapter 4 Discussion 
Yang, 2006) in order to increase the sensitivity. Moreover, as there was a significant 
decrease in brain infarction in double doses protocol，the treatment method in this 
enzyme activities experiment followed the double dose protocol. 
SOD function is the first line of defence against oxidative stress, by converting 
the superoxide anion to hydrogen peroxide. Therefore, increasing the SOD activity 
could reduce the oxidative injury in brain. There were significant increases in SOD 
activities of lOX HED treatment group. The enhancement of SOD activity may 
account for the decrease in brain infarction in lOX HED treatment group. 
4.3 The protective effects of SAB in in vivo middle cerebral artery (MCAo) model 
4.3.1 Free radical scavenging property of different herbs 
AAPH assays were carried out (Fig. 3.3a-g) to examine the free radical 
scavenging ability of different herbs that contained in PSR. Among seven herbs, the 
IC50 of Salvia miltiorrhiza Bunge (80 }ag/ml) was the lowest. Its free radical 
scavenging property was better than that of PSR (IC50： 130 |ag/ml). However, even 
Salvia miltiorrhiza Bunge possesses better anti-oxidative effect than that of PSR, it 
does not mean Salvia miltiorrhiza Bunge should have better protective effect toward 
ischemia brain. This is because, as mentioned before, compound formula can target 
130 
Chapter 4 Discussion 
different symptoms and prevent different complications, and also synergistic effect 
may occur between different herbs. 
Since Salvia miltiorrhiza Bunge could scavenge free radicals, it may help 
protecting the ischemia brain. Hence, it may contain active compound that could treat 
stroke. 
4.3.2 Selection of pure compound that used to treat stroke 
Since PSR could protect the brain from ischemia-reperfusion injury, its 
constituents should contain effective compound that could treat stroke. As oxidation is 
one of the major pathways of cerebral injury, the herb that showed the highest 
anti-oxidative ability, Salvia miltiorrhiza Bunge, may contain the effective compound. 
The major compounds that found in Salvia miltiorrhiza Bunge are Tanshinone I, IIA， 
IIB; cryptotanshinone; Salvianolic acids A, B and protocatechuic aldehyde (Zhou et 
al., 2005). Although Tanshinone IIA and IIB could protect the brain from cerebral 
stroke (Lam et al., 2003), they are lipophilic compound and should not contain in PSR. 
Thus, they were not chosen for further investigation. Salvianolic B (SAB) was chosen 
for further investigation since it is a hydrophilic compound, and hence should contain 
in PSR. Also, its high free radical scavenging activities may help protecting the 
ischemia brain (Zhao et al., 2008). Moreover, it was reported that SAB could improve 
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the motor function of the stroke rat and also inhibit the decrease in SOD and GPx 
level at the dosage of 10 mg/kg (Chen et al., 2000; Tang et al., 2006). Therefore, 
protective effect of SAB toward the ischemia brain in acute phase was tested. 
Furthermore, effect of SAB on memory retention and post-stroke depression was 
examined by using shuttle box escape experiment. 
4.3.3 Protective effect of Salvianolic B in MCAo experiment 
The protective effect of SAB toward the cerebral ischemia-reperfusion injury 
was carried out by using MCAo model and TTC staining. Again, 2-hour ischemia and 
24-hour reperfusion was carried out. However, SAB was given to the rats by 
intraperitoneal injection once after onset of reperfusion. An intraperitoneal injection 
was used because of the ease of administration and absorption. Moreover, the drug 
was given to the rat right after onset of reperfusion in order to increase the protective 
effect of the drug. Since intraperitoneal injection can be carried out even the rat is 
under anaesthesia, earlier treatment could be given to the rat. From the results (Fig. 
3.12), there was a significant decrease in brain infarction when the rats were treated 
by 40 mg/kg SAB. In the literature, there was a significant increase in SOD and GPx 
level (Chen et al.，2000) and significant improvement in motor function (Tang et al , 
2006) when the rats were treated by 10 mg/kg SAB. Unlike other literature, in this 
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experiment, higher dosage was needed to have a significant protective effect, and this 
may due to several reasons. First of all, pre-treatment was done by Chen's groups 
(Chen et al., 2000) instead of post-treatment. As mentioned before, an earlier 
treatment should give a better protective effect. Therefore, lower dosage of SAB 
could also give an effective protective effect. Secondly, SAB was given to the rat for 
14 days (once a day) in Tang's experiment (Tang et al., 2006). Thus, the total amount 
of SAB that the rats received is more than our experiment in which as only one drug 
administration was given to the rats. Thirdly, the purity of SAB used in this 
experiment (> 90%) was lower than that in Chen's experiments (Chen et al , 2000). As 
a result, higher dosage was needed to give a significant protective effect. 
In addition, there was little difference in brain infarction even the dosage of SAB 
increased from 10 mg/kg to 40 mg/kg. This may due to the reduction in brain 
infarction reached a plateau. Also, post-treatment limited the neuroprotective effect of 
SAB. Thus, there was no huge reduction in brain infarction even the concentration of 
SAB was increased by four times. 
4.3.4 The effect of SAB toward neurological deficits 
Neurological examination was carried out and the results showed that there was 
no significant improvement in motor function even the rats were treated by 40 mg/kg 
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SAB (Fig. 3.13). However, it was reported that SAB could improve the motor 
function of the stroked rat in chronic stage (Chen et al., 2000). In our experiment, it 
showed that SAB could not improve the motor function of the stroked rat in acute 
stage, and lengthening the treatment period may be needed for significant 
improvement of the motor ability. 
4.4 The effects of PSR and SAB on stroked rats' performance in Shuttle box 
escape experiment 
4.4.1 Establishment of shuttle box escape experiment 
Four days training sessions were given to the rats in order to let them learn how 
to prevent the electric shock. In the literature, 3 to 5 days training session was enough 
for avoidance acquisition. Moreover, 30 to 50 trials per session was commonly found 
in literature (Dimitrova and Getova-Spassova, 2006; Kato et al., 2000; Veerendra 
Kumar and Gupta, 2002). Therefore, 4 consecutive training sessions were assigned to 
the rats. Besides, 50 trials were given to the rats each day in order to increase the rate 
of avoidance acquisition. In the last day of training session, the rats with over 50% of 
conditioned responses and at least 4 consecutive conditioned responses were 
classified as successfully trained (Dimitrova and Getova-Spassova, 2006; Van der et 
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al., 2005). 5 minutes exploration time was given to the rat before the experiment 
begins. During this time, the rat was left in the shuttle box to explore freely. Such 
exploration time allows the rat familiar with the learning environment and hence 
minimizes its anxiety and fear (Stepanichev et al., 2005). Furthermore, there are 
several ways to improve the avoidance acquisition, including 3 days acclimatization, 
placing the rats in a dim and quiet environment. 
Light and tone signals were employed as conditioned response, according to the 
literature, the tone signal used was around 90 db ( Todd M, 2005; Kato et al, 2000). 
Thus, 92 db was used as conditioned signal. Actually, several factors affect the 
avoidance proficiency, including the type, duration and intensity of the unconditional 
aversive stimulus. Electric shock is a common unconditional aversive stimulus; it is 
safe and effective over a broad range. However, there are limitations about using 
electric shock as aversive stimulus. For example, the rat's urine and feces reduce the 
received intensity of foot shock (Todd M, 2005). Therefore, the grid floor was cleaned 
after each training session for minimizing the above problem. 
4.4.2 Effects of PSR and SAB on avoidance performance 
For the training series, when comparing the performance at the first and last day 
of training series, both groups showed a significant increase in the percentage of 
135 
Chapter 4 Discussion 
conditioned response (Fig. 3.14). This means the rats were learning how to prevent 
the electric shock by trial and error. Also, the performance between different groups at 
Day 4 was more or less the same (P > 0.05). It proved that the performances showed 
in testing series were not affected by intrinsic factor. 
In addition, there was no significant change in the percentage of conditioned 
response in sham operation group after the operation (Fig. 3.14). Hence, the shuttle 
box escape deficit was not due to the surgical procedures. Also, the retention loss 
(forgetting) was not observed in the sham operation group. Thus, the escape deficit 
that occurred in other groups was not due to retention loss. A significant decrease in 
avoidance performance was observed in control, 5X HED and lOX HED after the 
MCAo operation. The escape deficit was not due to the motor deficit that induced by 
MCAo. From the results of escapes latency (Fig. 3.16), the rats could escape to 
another compartment in 3 seconds, thus, 10 seconds is enough for the rats to escape. 
Therefore, the escape deficit that observed in the stroked rats was not due to retention 
loss and motor deficit. 
Shuttle box escape experiment was used to employ as a memory retention test, 
better memory retention should have better performance. It was reported that only 
striatum and cortex will be injured if the rat received 30 minutes MCAo. If the rat 
exposed to MCAo for 2 hours, not only striatum and cortex will be damaged，but also 
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hippocampus. Such results were consistent with our findings. As mentioned before, 
hippocampus was infarcted after 2 hours ischemia and 24 hours reperfusion. Since 
hippocampal neurons play an important role in learning and memory processes, 
impairment of memory could be observed after MCAo operation. Therefore, the 
MCAo-induced shuttle box escape deficit may due to the impaired memory (Yun et 
al., 2007). In fact, there was a significant decrease in avoidance response in control, 
5X HED and lOX HED after the MCAo operation (Fig. 3.14). Such MCAo-induced 
shuttle box escape deficit may due to impairment of memory. 
While there was a relation between the brain lesion and memory retention, better 
cerebral protection should have better memory retention. Therefore, the brain 
infarction volumes were determined on the last day of testing series to check if there 
is any linkage between brain infarction volume and shuttle box escape performance. 
There were significant decreases (P < 0.05) in brain infarction when the stroked rats 
were treated by lOX HED of PSR or 40 mg/kg of SAB (Fig. 3.18). Also，for the 
avoidance performance on the first day testing series (Fig. 3.15), there were 
significant increases (P <0.05) in avoidance performance when comparing sham, lOX 
HED and 40 mg/kg SAB treatment group to control groups. As lOX HED and 40 
mg/kg SAB treatments could reduce the brain lesion size, the rats should have better 
memory retention, and hence, better avoidance performance in shuttle box escape 
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experiment. Since there was no brain lesion could be found in sham operation group, 
no memory impairment should be induced. Therefore, the avoidance performance of 
the sham operation was better than that of control group and no significant change 
after MCAo operation. 
4.4.3 Effects of PSR and SAB on escape latency 
Apart from memory lost, post-stroke depression (PSD) is a common 
complication that found in stroked patients, and the behavioural change that reflects 
post-stroke depression can be found in the stroked rats (Kato et al., 2000). A 
parameter that could reflect depression is escape latency. Escape latency was defined 
as the time between unconditional aversive stimulus (electric shock) onset and an 
escape response (Todd M, 2005). It was reported that the animal with depression had 
longer escape latency. In the literatures, depression was usually induced by 
inescapable and uncontrollable stress which known as "learned helplessness" 
(Dishman et al., 1997; Costela et al., 1995). In our experiment, depression was 
induced by MCAo operation. Although the cause of depression was different, escape 
latency was employed to assess the severity of the PSD. 
For the results, there was no significant difference in escape latency between 
different groups on the last day of training series (Fig. 3.16). Again, the rats in sham 
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operation group were not stroked, and no PSD was induced. Therefore, their escape 
latency did not have a significant change after the operation. However, a significant 
increase in escape latency was found in control, 5X HED and 40 mg/kg SAB 
treatment group after MCAo operation. Such increase may due to post-stroke 
depression. On the first day of testing series, only 1 OX HED treatment group showed 
significant decrease in escape latency when comparing with that of control group (Fig. 
3.17). Such reductions represent that PSR may be effective in treating PSD. 
Actually, the increase in escape latency may due to other factors. Besides 
depression, the change in pain threshold also affects the escape latency. The 
magnitude of aversive stimulus that the rat received may affect the motivation of 
escape (Todd M, 2005). Although this factor (change in pain threshold) cannot be 
eliminated in this study alone, but the following fact argue against this explanation: 
MCAo operation only induced stroke on the left hand side of the body, and the 
sensory ability of right hand side was not affected. Therefore, all the rats could 
receive the electric shock with same magnitude on the non-affected side. However, 
since the present study only showed the escape latency could be reduced by treating 
PSR, the underlying mechanism should be further tested in order to find out whether 
PSR could reduce the PSD or sensory deficits. 
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4.5 Assessment on the contribution of SAB to the protective effect of PSR 
The ratio of Danshen : PSR = 1 : 49 
The estimated amount of SAB in Danshen = 0.683 % (Lam et al., 2006) 
The estimated amount of SAB in lOX HED of PSR = 1.56 x (1/49) x (6.83 x 10'^ ) 
=0.217 mg 
The estimated amount of SAB (0.217 mg/rat) contained in lOX HED of PSR is 
much lower than the amount of SAB (10 mg/rat) used in 40 mg/kg SAB treatment 
group. However, the reduction of brain infarction in lOX HED PSR treatment group 
and in 40 mg/kg SAB treatment was similar. This implied that, the protective effect of 
PSR was not solely contributed by SAB but also other compounds. Moreover, only 
treatment of 1 OX HED of PSR could significantly improve the motor function of the 
stroked rats and significantly reduced the escape latency time. Those results suggested 
that PSR should contain other effective compounds. However, further investigations 
are needed to find out the effective compounds contained in PSR. 
4.6 Comparison of acute and chronic testing 
4.6.1 The protective effect of the drugs (Histopathological examination) 
Both long term (Day 10 in shuttle box escape experiment) and short term (2-hour 
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ischemia and 24-hours reperfusion) treatment of PSR or SAB could significantly 
reduce the brain infarction volume (Fig. 3.7，Fig. 3.12 and Fig. 3.18). However, the 
brain infarction volume (percentage of control) did not show significant difference 
between long term and short term treatments. As mentioned before, the irreversible 
damage within the infarct core have already developed during ischemia period. This 
limits the protective effect of the drugs. Therefore, the variation of brain infarction 
volume between different treatment methods is limited. 
4.6.2 The severity of motor deficit (Neurological score) 
There was a significant improvement of motor function when the rat was treated 
by lOX HED of PSR (Fig. 3.8). However, no significant difference between treatment 
and control group was observed on the first day of testing series in shuttle box escape 
experiment (Fig. 3.19). Actually, the recovery of the motor deficit would be occurred 
in the first week after stroke (Li et al., 2004). The neurological score of the control 
group after 24 hours of reperfusion was consistently 3, and it dropped to 2.45 on the 
last day of testing series in shuttle box escape experiment. Therefore, the difference of 
the motor deficit between different groups may be minimized. Nevertheless, there was 
a significant improvement of the motor function on Day 9 and Day 10 when the rats 
were treated by 1 OX HED of PSR. These results suggest that better motor recovery 
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could be found if 6 consecutive days of lOX HED PSR treatments were given to the 
rats. 
Moreover, unlike the results from histopathological examination, there was a 
significant improvement (P < 0.05) in motor function when comparing the 
neurological score at Day 10 in shuttle box escape experiment to that at 24 hours after 
reperfusion. It means that longer term of treatment would give a better improvement 
in motor function. 
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Conclusion and Future prospect 
5.1 Conclusion 
Chinese compound formula, PSR, could reduce the human neuroblastoma cell 
death in oxygen and glucose deprivation (OGD) model in a dose-dependent manner. 
Besides, an AAPH-induced hemolysis assay demonstrated the free radical scavenging 
property of PSR. In addition, both PSR and SAB have been found to be effective in 
protecting the brain from ischemia-reperfusion damage. Moreover，PSR enhanced the 
activity of an anti-oxidative enzyme, namely superoxide dismutase, in the brain. This 
result suggests that post-treatment of PSR at 1 and 2 hours after the onset of 
reperfusion attenuated the cerebral ischemia-reperfusion injury in the brain of the rats 
by its anti-oxidative property. For the shuttle box escape experiment, a significant 
improvement in avoidance was observed when the rats were treated by PSR or SAB 
for 4 consecutive days. Such improvement may be through the enhancement of 
memory retention since the drugs could reduce the brain infarction volume. 
Furthermore, the motor function was also significantly improved when the rats were 
treated by lOX HED of PSR for 6 consecutive days. These findings suggest that 
treatment of PSR should give a better performance in post-stroke rehabilitation. 
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5.2 Future prospect 
Only post-treatment was conducted in this study. Actually, pre-treatment may 
give better neuroprotective effect (Khayyam et al., 1999; Tang et a l , 2007; Costa et 
al., 2006). Therefore，pre-treatment of PSR could also be carried out to check if there 
is improvement in its neuroprotective effect. 
Moreover, the beauty of Chinese compound formula is that different herbs can 
target different symptoms and prevent different complications. Thus, the compound 
formula does not target single mechanism, and further mechanistic studies are needed 
to demonstrate the underlying neuroprotection pathway of PSR. Apart from 
anti-oxidative ability, glutamate receptor blockage, anti-inflammatory and 
anti-apoptotic ability of PSR could also be tested. As mentioned before, both 
excessive release of glutamate, inflammation and apoptosis contribute to 
ischemia-reperfusion cerebral damage. Several evidences indicated that PSR may 
protect the brain through other pathways. It was reported that Radix Salviae 
Miltorrhizae is a NMDA blocker (Sun et al., 2003). Thus, it may protect the brain 
through blockage of NMDA receptor. Besides, Radix Astragali could reduce the 
caspase-3 expression in hypoxia-ischemia brain (Jia et a l , 2003). Furthermore, 
astragaloside IV decreased the LPS-stimulated expression of adhesion molecules 
(Zhang et al., 2003). Therefore, other mechanistic studies could be carried out to give 
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a comprehensive picture about the neuroprotective mechanisms of PSR. 
Treatment of PSR reduced the escape latency in shuttle box escape experiment. 
Since both post-stroke depression and sensory ability affect the escape latency, further 
studies should be carried out to test if PSR could reduce depression or improve 
sensory ability of the stroked rat. Experimental model of depression (Learned 
helplessness) could be employed to test if the drugs could reduce depression (Costela 
et al., 1995; Dishman et al., 1997). Besides, adhesive tape test has widely been 
employed in assessing the sensory deficit of the rat (Pan et al., 2005). Hence, the 
effect of PSR on sensory ability could be tested by using these tests. 
Recently, more studies concern about neurogenesis in ischemic brain. In fact, 
neurogenesis can be found in the subventricular zone (SVZ) and the subgranular zone 
(SGZ) of adult mammalian brain. Interestingly, apart from inducing cell death, 
cerebral stroke also induces neurogenesis in hippocampal, cerebral cortex, and 
striatum. Theoretically, better endogenous neurogenesis favors brain self-repair 
(Parent et al., 2002; Arvidsson et a l , 2002). It was reported that consecutive treatment 
of 10 mg/kg SAB for 14 days could significantly enhance the neurogenesis in the 
SGZ in the dentate gyrus of the hippocampus (Tang et al., 2006). Therefore, the 
neurogenesis effect of PSR on stroked rat could also be tested by using 
5-bromo-2-deoxyuridine (BrdU) staining method. In conclusion, more tests should be 
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performed in order to illustrate the mechanism of the protective effect of PSR on 
post-stroke rehabilitation of rats and patients. 
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